<SEC-DOCUMENT>0001193125-22-228896.txt : 20221031
<SEC-HEADER>0001193125-22-228896.hdr.sgml : 20221031
<ACCEPTANCE-DATETIME>20220824212537
ACCESSION NUMBER:		0001193125-22-228896
CONFORMED SUBMISSION TYPE:	POS EX
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20220825
DATE AS OF CHANGE:		20220824
EFFECTIVENESS DATE:		20220825

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GDL FUND
		CENTRAL INDEX KEY:			0001378701
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POS EX
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-250213
		FILM NUMBER:		221192809

	BUSINESS ADDRESS:	
		STREET 1:		ONE CORPORATE CENTER
		CITY:			RYE
		STATE:			NY
		ZIP:			10580
		BUSINESS PHONE:		914-921-5100

	MAIL ADDRESS:	
		STREET 1:		ONE CORPORATE CENTER
		CITY:			RYE
		STATE:			NY
		ZIP:			10580

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gabelli Global Deal Fund
		DATE OF NAME CHANGE:	20061019
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS EX
<SEQUENCE>1
<FILENAME>d388267dposex.htm
<DESCRIPTION>GDL FUND
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:cik0001378701="http://www.gabelli.com/20220824" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>GDL Fund</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body><div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P08_24_2022To08_24_2022">0001378701</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P08_24_2022To08_24_2022">false</ix:nonNumeric><ix:nonNumeric name="dei:DocumentType" contextRef="P08_24_2022To08_24_2022">POS EX</ix:nonNumeric><ix:nonNumeric name="dei:EntityWellKnownSeasonedIssuer" id="hidden55199872" contextRef="P08_24_2022To08_24_2022">No</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="cik0001378701-20220824.xsd"/><link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cik0001378701-20220824_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/><link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cik0001378701-20220824_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/><link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cik0001378701-20220824_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/></ix:references><ix:resources><xbrli:context id="P08_24_2022To08_24_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001378701</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-08-24</xbrli:startDate> <xbrli:endDate>2022-08-24</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001378701</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-08-24</xbrli:startDate> <xbrli:endDate>2022-08-24</xbrli:endDate> </xbrli:period> </xbrli:context></ix:resources></ix:header></div><div style="background-color:white;display: inline;"><div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">As filed with the Securities and Exchange Commission on August 24, 2022 </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:right">Securities Act File No.&#160;333-250213 </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:right">Investment Company Act File <div style="white-space:nowrap;display:inline;">No.&#160;811-21969</div> </div><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="margin-top:4pt; margin-bottom:0pt; font-size:13pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:13pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, DC 20549 </div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:16%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:13pt; font-family:Times New Roman;font-weight:bold;text-align:center">Form <div style="white-space:nowrap;display:inline;">N-2</div> </div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:16%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:center"><div style="font-weight:bold;display:inline;">(Check Appropriate Box or Boxes) </div><div style="font-weight:bold;display:inline;"> </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9746;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><div style="font-weight:bold;display:inline;">REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</div> </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">Pre-Effective</div> Amendment No.</div> </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9746;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><div style="font-weight:bold;display:inline;">Post-Effective Amendment No. 1</div> </div></td></tr></table></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">and/or </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9746;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><div style="font-weight:bold;display:inline;">REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940</div> </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9746;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><div style="font-weight:bold;display:inline;">Amendment No.</div><div style="font-weight:bold;display:inline;">&#160;25</div> </div></td></tr></table></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:16%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:2pt; margin-bottom:0pt; font-size:19pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P08_24_2022To08_24_2022">THE GDL FUND</ix:nonNumeric>&#8203;&#8203;&#8203;&#8203;&#8203;&#8203;&#8203; </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as specified in Charter) </div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:16%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P08_24_2022To08_24_2022">One Corporate Center</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P08_24_2022To08_24_2022">Rye</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="P08_24_2022To08_24_2022" format="ixt-sec:stateprovnameen">New York</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P08_24_2022To08_24_2022">10580-1422</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices) </div><div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, including Area Code: (<ix:nonNumeric name="dei:CityAreaCode" contextRef="P08_24_2022To08_24_2022">800</ix:nonNumeric>) <div style="white-space:nowrap;display:inline;"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="P08_24_2022To08_24_2022">422-3554</ix:nonNumeric></div> </div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:16%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div><div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:ContactPersonnelName" contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">John C. Ball</ix:nonNumeric> </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">The GDL Fund </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">One Corporate Center</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Rye</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" format="ixt-sec:stateprovnameen">New York</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">10580-1422</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(914) <div style="white-space:nowrap;display:inline;">921-5070</div> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Name and Address of Agent for Service) </div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:16%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><div style="font-style:italic;display:inline;">Copies to: </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:23%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:28%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:26%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:20%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Peter Goldstein, Esq.</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">The GDL Fund</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Thomas A. DeCapo, Esq.</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Kenneth E. Burdon, Esq.</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">One Corporate Center</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">Skadden,&#160;Arps,&#160;Slate,&#160;Meagher&#160;&amp;&#160;Flom&#160;LLP</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">Rye, New York 10580-1422</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">500 Boylston Street</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">(914) <div style="white-space:nowrap;display:inline;">921-5100</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">Boston, Massachusetts 02116</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">(617) <div style="white-space:nowrap;display:inline;">573-4800</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/></tr></table><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:16%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><div style="font-weight:bold;display:inline;">Approximate Date of Commencement of Proposed Public Offering:</div> From time to time after the effective date of this Registration Statement. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Check box if the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans. </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9745;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Check box if any securities being registered on this Form will be offered on a delayed or continuous basis in reliance on Rule 415 under the Securities Act of 1933 (&#8220;Securities Act&#8221;), other than securities offered in connection with a dividend reinvestment plan. </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9745;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Check box if this Form is a registration statement pursuant to General Instruction A.2 or a post-effective amendment thereto. </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Check box if this Form is a registration statement pursuant to General Instruction B or a post-effective amendment thereto that will become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act. </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Check box if this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction B to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act. </div></td></tr></table><div style="margin-top:8pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">It is proposed that this filing will become effective (check appropriate box): </div><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">when declared effective pursuant to section 8(c) of the Securities Act </div></td></tr></table><div style="margin-top:8pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If appropriate, check the following box: </div><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">This [post-effective] amendment designates a new effective date for a previously filed [post-effective amendment] [registration statement]. </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">This Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is: <div style="text-decoration:underline;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>. </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:NoSubstantiveChanges462c" contextRef="P08_24_2022To08_24_2022" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">This Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is: <div style="text-decoration:underline;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>. </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:ExhibitsOnly462d" contextRef="P08_24_2022To08_24_2022" format="ixt:fixed-true">&#9745;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">This Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is: 333-250213. </div></td></tr></table></div><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">Check</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">each box that appropriately characterizes the Registrant: </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9745;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Registered <div style="white-space:nowrap;display:inline;">Closed-End</div> Fund <div style="white-space:nowrap;display:inline;">(closed-end</div> company that is registered under the Investment Company Act of 1940 (the &#8220;Investment Company Act&#8221;)). </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Business Development Company <div style="white-space:nowrap;display:inline;">(closed-end</div> company that intends or has elected to be regulated as a business development company under the Investment Company Act. </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Interval Fund (Registered <div style="white-space:nowrap;display:inline;">Closed-End</div> Fund or a Business Development Company that makes periodic repurchase offers under Rule <div style="white-space:nowrap;display:inline;">23c-3</div> under the Investment Company Act). </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9745;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">A.2 Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form). </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left"><span style="-sec-ix-hidden:hidden55199872">Well</span>-Known Seasoned Issuer (as defined by Rule 405 under the Securities Act). </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="P08_24_2022To08_24_2022" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Emerging Growth Company (as defined by Rule <div style="white-space:nowrap;display:inline;">12b-2</div> under the Securities and Exchange Act of 1934). </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act. </div></td></tr></table><div style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">New Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months preceding this filing). </div></td></tr></table></div> <div style="background-color:white;display: inline;"><div> </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Explanatory Note </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Post-Effective Amendment No. 1 to the Registration Statement on Form N-2 (File No. 333-250213) of The GDL Fund (the &#8220;Registration Statement&#8221;) is being filed pursuant to Rule 462(d) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), solely for the purpose of filing exhibits to the Registration Statement. Accordingly, this Post-Effective Amendment No. 1 consists only of a facing page, this explanatory note and Part C of the Registration Statement on Form N-2 setting forth the exhibits to the Registration Statement. This Post-Effective Amendment No. 1 does not modify any other part of the Registration Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Rule 462(d) under the Securities Act, this Post-Effective Amendment No. 1 shall become effective immediately upon filing with the Securities and Exchange Commission. The contents of the Registration Statement are hereby incorporated by reference. </p> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PART C </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">OTHER INFORMATION </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;25.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">1.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Financial Statements </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">Part A </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:11%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/0001378701/000138713122003436/gdl-ncsr_123121.htm">The audited financial statements included in the annual report to the Fund&#8217;s shareholders for the fiscal year ended December 31, 2021 (the &#8220;2021 Annual Report&#8221;), together with the report of PricewaterhouseCoopers LLP thereon, are incorporated by reference to the 2021 Annual Report in Part A. </a> </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:11%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/0001378701/000138713121003323/gdl-ncrs_123120.htm">The audited financial statements included in the annual report to the Fund&#8217;s shareholders for the fiscal year ended December&#160;31, 2020 (the &#8220;2020 Annual Report&#8221;), together with the report of Ernst &amp; Young LLP thereon, are incorporated by reference to the 2020 Annual Report in Part A. </a> </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:11%; font-size:10pt; font-family:Times New Roman">The Financial Highlights included in the annual report to the Fund&#8217;s shareholders for the fiscal year ended December&#160;31, 2015 (the &#8220;2015 Annual Report&#8221;), are incorporated by reference to the 2015 Annual Report in Part A. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">Part B </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:11%; font-size:10pt; font-family:Times New Roman">None </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">2.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Exhibits </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:89%;border:0;margin-left:auto">


<tr>

<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:96%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(a)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/1378701/000094040011000092/ggdeal77q11.txt">(i)&#8195;Amended and Restated Agreement and Declaration of Trust of Registrant (1) </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/1378701/000119312518047286/d538450dex99aiii.htm">(ii)&#8194;&#8201;Statement of Preferences for the Series C Cumulative Puttable and Callable Preferred Shares (2) </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iii)&#8201;&#8201;<a href="d388267dex99aiii.htm">Statement of Preferences for the Series E Cumulative Term Preferred Shares** </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iv)&#8194;Statement of Preferences for &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Cumulative Preferred Shares *</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(b)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/1378701/000094040011000092/ggdeal77q12.txt">(i)&#8195;Amended and Restated <span style="white-space:nowrap">By-Laws</span> of Registrant (1) </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><a href="d388267dex99bii.htm">(ii)&#8194;&#8201;Amendment No. 1 to Amended and Restated By-Laws of Registrant** </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(c)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Not applicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(d)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/1378701/000095012307000818/y28144a4exv99wd.htm">(i)&#8195;Form of Specimen Common Share Certificate (3) </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(ii)&#8194;&#8201;Form of Subscription Certificate for Common Shares *</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iii)&#8201;&#8201;Form of Subscription Certificate for [&#160;&#160;&#160;&#160;]% Series &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Cumulative Preferred Shares *</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iv)&#8194;Form of Subscription Certificate for Common Shares and [&#160;&#160;&#160;&#160;]% Series &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Cumulative Preferred Shares&#160;*</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(v)&#8194;&#8201;&#8202;<a href="http://www.sec.gov/Archives/edgar/data/1378701/000119312520298289/d15753dex99dv.htm">Form of Indenture (4) </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(vi)&#8194;Form <span style="white-space:nowrap">T-1</span> Statement of Eligibility of Trustee with respect to the Form of Indenture *</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(e)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1378701/000119312520239899/d68307dncsrs.htm">Automatic Dividend Reinvestment and Voluntary Cash Purchase Plans of Registrant (5) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(f)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Not applicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(g)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1378701/000134100406003484/exhibit_g.txt">Form of Investment Advisory Agreement between Registrant and Gabelli Funds, LLC (6) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(h)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(i)&#8195;Form of Underwriting Agreement *</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(ii)&#8194;&#8201;Form of Dealer Manager Agreement *</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(i)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Not applicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(j)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1378701/000095012307000818/y28144a4exv99wj.htm">Form of Custodian Contract (3) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(k)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/1378701/000095012307000818/y28144a4exv99wk.htm">(i)&#8195;Form of Transfer Agency and Registrar Services Agreement (3) </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/1378701/000119312518047286/d538450dex99kii.htm">(a)&#8194;&#8201;&#8202;Form of Addendum to Transfer Agency and Registrar Services Agreement (2) </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(ii)&#8194;&#8201;Form of Rights Agent Agreement *</p></td></tr></table></div> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:89%;border:0;margin-left:auto">


<tr>

<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:96%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iii)&#8201;&#8201;Form of Information Agent Agreement *</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(l)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1378701/000119312521041951/d109724dex99l.htm">Opinion and Consent of Skadden, Arps, Slate, Meagher&#160;&amp; Flom LLP with respect to legality (7)</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(m)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Not applicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(n)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(i)&#8195;Consent of Independent Registered Public Accounting Firm (9)</p></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iii)&#8201;&#8201;Consent and Independent Registered Public Accounting Firm (8)</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(o)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Not applicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(p)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Not applicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(q)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Not applicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(r)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1378701/000119312520298289/d15753dex99r.htm">Code of Ethics of the Fund and the Investment Adviser (4) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(s)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(i)&#8195;<a href="http://www.sec.gov/Archives/edgar/data/1378701/000119312520298289/d15753dex99si.htm">Powers of Attorney of the Registrant&#8217;s Trustees, except Agnes Mullady (4) </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(ii)&#8194;&#8201;Power of Attorney of Agnes Mullady (9)</p></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iii)&#8201;&#8201;<a href="http://www.sec.gov/Archives/edgar/data/1378701/000119312520298289/d15753dex99sii.htm">Form of Prospectus Supplement Relating to Common Shares (4) </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iv)&#8194;<a href="http://www.sec.gov/Archives/edgar/data/1378701/000119312520298289/d15753dex99siii.htm">Form of Prospectus Supplement Relating to Preferred Shares (4) </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(v)&#8194;&#8201;&#8202;<a href="http://www.sec.gov/Archives/edgar/data/1378701/000119312520298289/d15753dex99siv.htm">Form of Prospectus Supplement Relating to Notes (4) </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(vi)&#8194;<a href="http://www.sec.gov/Archives/edgar/data/1378701/000119312520298289/d15753dex99sv.htm">Form of Prospectus Supplement Relating to Subscription Rights to Purchase Common Shares (4) </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(vii)&#8201;<a href="http://www.sec.gov/Archives/edgar/data/1378701/000119312520298289/d15753dex99svi.htm">Form of Prospectus Supplement Relating to Subscription Rights to Purchase Preferred Shares (4) </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(viii)<a href="http://www.sec.gov/Archives/edgar/data/1378701/000119312520298289/d15753dex99svii.htm">Form of Prospectus Supplement Relating to Subscription Rights to Purchase Common and Preferred Shares&#160;(4) </a></p></td></tr>
</table></div> </div> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to the Registrant&#8217;s Form <span style="white-space:nowrap">N-SAR,</span> as filed with the Securities and Exchange Commission on March&#160;1, 2011. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to the Registrant&#8217;s Post-Effective Amendment No.&#160;1 to its Registration Statement on Form <span style="white-space:nowrap">N-2,</span> File Nos. <span style="white-space:nowrap">333-213902</span> and <span style="white-space:nowrap">811-21969,</span> as filed with the Securities and Exchange Commission on February&#160;15, 2018. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to the Registrant&#8217;s <span style="white-space:nowrap">Pre-Effective</span> Amendment No.&#160;4 to its Registration Statement on Form <span style="white-space:nowrap">N-2,</span> File Nos. <span style="white-space:nowrap">333-138141</span> and <span style="white-space:nowrap">811-21969,</span> as filed with the Securities and Exchange Commission on January&#160;26, 2007. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Previously filed with the Registrant&#8217;s Registration Statement on Form N-2, File Nos. 333-250213 and 811-21969, as filed with the Securities and Exchange Commission on November 19, 2020. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(5)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to the Registrant&#8217;s Annual Report for the reporting period December 31, 2020 on Form N-CSR, File No. 811-21969 as filed with the Securities and Exchange Commission on March 8, 2021. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(6)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to the Registrant&#8217;s <span style="white-space:nowrap">Pre-Effective</span> Amendment No.&#160;1 to its Registration Statement on Form <span style="white-space:nowrap">N-2,</span> File Nos. <span style="white-space:nowrap">333-138141</span> and <span style="white-space:nowrap">811-21969,</span> as filed with the Securities and Exchange Commission on December&#160;13, 2006. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(7)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Previously filed with the Registrant&#8217;s Pre-Effective No. 1 to its Registration Statement on Form N-2, File Nos. 333-250213 and 811-21969, as filed with the Securities and Exchange Commission on February 12, 2021. </p></td></tr></table> <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(8)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to the Registrant&#8217;s Annual Report on Form N-CSR for the year ended December 31, 2021, as filed with the Securities and Exchange Commission on March 9, 2022 </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(9)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to the Registrant&#8217;s Pre-Effective Amendment No. 2 to the Registration Statement on Form N-2, File Nos. 333-250213 and 811-21969, as filed with the Securities and Exchange Commission on May 11, 2021. </p></td></tr></table> </div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To be filed by Amendment. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">**</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Filed herewith. </p></td></tr></table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;26.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Marketing Arrangements </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">The information contained under the heading &#8220;Plan of Distribution&#8221; in the Prospectus is incorporated by reference, and any information concerning any underwriters will be contained in the accompanying Prospectus Supplement, if any. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;27.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Expenses of Issuance and Distribution </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">The following table sets forth the estimated expenses to be incurred in connection with the offering described in this Registration Statement: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:55%;border:0;margin:0 auto">


<tr>

<td style="width:87%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$21,820</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NYSE listing fee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$68,496</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rating Agency fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$50,000</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing/engraving expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$300,000</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Auditing fees and expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$55,000</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$452,000</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA Fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$18,500</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$200,184</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$1,166,000</td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;28.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Persons Controlled by or Under Common Control with Registrant </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">None. </p>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;29.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Number of Holders of Securities as of August 1, 2022 </p></td></tr></table> </div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:67%;border:0;margin:0 auto">


<tr>

<td style="width:86%"/>

<td style="vertical-align:bottom;width:11%"/>
<td style="width:28pt"/>
<td/>
<td/>
<td style="width:28pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Title of Class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="4" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number&#160;of<br/>&#160;Record&#160;Holders&#160;</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Shares</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">14</td>
<td style="white-space:nowrap;vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C Cumulative Puttable and Callable Preferred Shares</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series E Cumulative Preferred</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">24</td>
<td style="white-space:nowrap;vertical-align:bottom"/></tr>
</table> </div> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;30.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Indemnification </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article IV of the Registrant&#8217;s Amended and Restated Agreement and Declaration of Trust provides as follows: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">4.1 No Personal Liability of Shareholders, Trustees, etc. No Shareholder of the Trust shall be subject in such capacity to any personal liability whatsoever to any Person in connection with Trust Property or the acts, obligations or affairs of the Trust. Shareholders shall have the same limitation of personal liability as is extended to stockholders of a private corporation for profit incorporated under the general corporation law of the State of Delaware. No Trustee or officer of the Trust shall be subject in such capacity to any personal liability whatsoever to any Person, other than the Trust or its Shareholders, in connection with Trust Property or the affairs of the Trust, save only liability to the Trust or its Shareholders arising from bad faith, willful misfeasance, gross negligence or reckless disregard for his duty to such Person; and, subject to the foregoing exception, all such Persons shall look solely to the Trust Property for satisfaction of claims of any nature arising in connection with the affairs of the Trust. If any Shareholder, Trustee or officer, as such, of the Trust, is made a party to any suit or proceeding to enforce any such liability, subject to the foregoing exception, he shall not, on account thereof, be held to any personal liability. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">4.2 Mandatory Indemnification . (a) The Trust shall indemnify the Trustees and officers of the Trust (each such person being an &#8220;indemnitee&#8221;) against any liabilities and expenses, including amounts paid in satisfaction of judgments, in compromise or as fines and penalties, and reasonable counsel fees reasonably incurred by such indemnitee in connection with the defense or disposition of any action, suit or other proceeding, whether civil or criminal, before any court or administrative or investigative body in which he may be or may have been involved as a party or otherwise (other than, except as authorized by the Trustees, as the plaintiff or complainant) or with which he may be or may have been threatened, while acting in any capacity set forth above in this Section&#160;4.2 by reason of his having acted in any such capacity, except with respect to any matter as to which he shall not have acted in good faith in the reasonable belief that his action was in the best interest of the Trust or, in the case of any criminal proceeding, as to which he shall have had reasonable cause to believe that the conduct was unlawful, provided, however, that no indemnitee shall be indemnified hereunder against any liability to any person or any expense of such indemnitee arising by reason of (i)&#160;willful misfeasance, (ii)&#160;bad faith, (iii)&#160;gross negligence (negligence in the case of Affiliated Indemnitees), or (iv)&#160;reckless disregard of the duties involved in the conduct of his position (the conduct referred to in such clauses (i)&#160;through (iv) being sometimes referred to herein as &#8220;disabling conduct&#8221;). Notwithstanding the foregoing, with respect to any action, suit or other proceeding voluntarily prosecuted by any indemnitee as plaintiff, indemnification shall be mandatory only if the prosecution of such action, suit or other proceeding by such indemnitee was authorized by a majority of the Trustees. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, no indemnification shall be made hereunder unless there has been a determination (1)&#160;by a final decision on the merits by a court or other body of competent jurisdiction before whom the issue of entitlement to indemnification hereunder was brought that such indemnitee is entitled to indemnification hereunder or, (2)&#160;in the absence of such a decision, by (i)&#160;a majority vote of a quorum of those Trustees who are neither Interested Persons of the Trust nor parties to the proceeding (&#8220;Disinterested <span style="white-space:nowrap">Non-Party</span> Trustees&#8221;), that the indemnitee is entitled to indemnification hereunder, or (ii)&#160;if such quorum is not obtainable or even if obtainable, if such majority so directs, independent legal counsel in a written opinion conclude that the indemnitee should be entitled to indemnification hereunder. All determinations to make advance payments in connection with the expense of defending any proceeding shall be authorized and made in accordance with the immediately succeeding paragraph (c)&#160;below. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">(c) The Trust shall make advance payments in connection with the expenses of defending any action with respect to which indemnification might be sought hereunder if the Trust receives a written affirmation by the indemnitee of the indemnitee&#8217;s good faith belief that the standards of conduct necessary for indemnification have been met and a written undertaking to reimburse the Trust unless it is subsequently determined that he is entitled to such indemnification and if a majority of the Trustees determine that the applicable standards of conduct necessary for indemnification appear to have been met. In addition, at least one of the following conditions must be met: (1)&#160;the indemnitee shall provide adequate security for his undertaking, (2)&#160;the Trust shall be insured against losses arising by reason of any lawful advances, or (3)&#160;a majority of a quorum of the Disinterested <span style="white-space:nowrap">Non-Party</span> Trustees, or if a majority vote of such quorum so direct, independent legal counsel in a written opinion, shall conclude, based on a review of readily available facts (as opposed to a full trial-type inquiry), that there is substantial reason to believe that the indemnitee ultimately will be found entitled to indemnification. </p>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">(d) The rights accruing to any indemnitee under these provisions shall not exclude any other right to which he may be lawfully entitled. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding the foregoing, subject to any limitations provided by the 1940 Act and this Declaration, the Trust shall have the power and authority to indemnify Persons providing services to the Trust to the full extent provided by law as if the Trust were a corporation organized under the Delaware General Corporation Law provided that such indemnification has been approved by a majority of the Trustees. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">4.3 No Duty of Investigation; Notice in Trust Instruments, etc. No purchaser, lender, transfer agent or other person dealing with the Trustees or with any officer, employee or agent of the Trust shall be bound to make any inquiry concerning the validity of any transaction purporting to be made by the Trustees or by said officer, employee or agent or be liable for the application of money or property paid, loaned, or delivered to or on the order of the Trustees or of said officer, employee or agent. Every obligation, contract, undertaking, instrument, certificate, Share, other security of the Trust, and every other act or thing whatsoever executed in connection with the Trust shall be conclusively taken to have been executed or done by the executors thereof only in their capacity as Trustees under this Declaration or in their capacity as officers, employees or agents of the Trust. The Trustees may maintain insurance for the protection of the Trust Property, its Shareholders, Trustees, officers, employees and agents in such amount as the Trustees shall deem adequate to cover possible liability, and such other insurance as the Trustees in their sole judgment shall deem advisable or is required by the 1940 Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">4.4 Reliance on Experts, etc. Each Trustee and officer or employee of the Trust shall, in the performance of its duties, be fully and completely justified and protected with regard to any act or any failure to act resulting from reliance in good faith upon the books of account or other records of the Trust, upon an opinion of counsel, or upon reports made to the Trust by any of the Trust&#8217;s officers or employees or by any advisor, administrator, manager, distributor, selected dealer, accountant, appraiser or other expert or consultant selected with reasonable care by the Trustees, officers or employees of the Trust, regardless of whether such counsel or other person may also be a Trustee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Section&#160;9 of the Registrant&#8217;s Investment Advisory Agreement provides as follows: </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. Indemnity </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">(a) The Fund hereby agrees to indemnify the Adviser and each of the Adviser&#8217;s trustees, officers, employees, and agents (including any individual who serves at the Adviser&#8217;s request as director, officer, partner, trustee or the like of another corporation) and controlling persons (each such person being an &#8220;indemnitee&#8221;) against any liabilities and expenses, including amounts paid in satisfaction of judgments, in compromise or as fines and penalties, and counsel fees (all as provided in accordance with applicable corporate law) reasonably incurred by such indemnitee in connection with the defense or disposition of any action, suit or other proceeding, whether civil or criminal, before any court or administrative or investigative body in which he may be or may have been involved as a party or otherwise or with which he may be or may have been threatened, while acting in any capacity set forth above in this paragraph or thereafter by reason of his having acted in any such capacity, except with respect to any matter as to which he shall have been adjudicated not to have acted in good faith in the reasonable belief that his action was in the best interest of the Fund and furthermore, in the case of any criminal proceeding, so long as he had no reasonable cause to believe that the conduct was unlawful, provided, however, that (1)&#160;no indemnitee shall be indemnified hereunder against any liability to the Fund or its shareholders or any expense of such indemnitee arising by reason of (i)&#160;willful misfeasance, (ii)&#160;bad faith, (iii)&#160;gross negligence, (iv)&#160;reckless disregard of the duties involved in the conduct of his position (the conduct referred to in such clauses (i)&#160;through (v) being sometimes referred to herein as &#8220;disabling conduct&#8221;), (2) as to any matter disposed of by settlement or a compromise payment by such indemnitee, pursuant to a consent decree or otherwise, no indemnification either for said payment or for any other expenses shall be provided unless there has been a determination that such settlement or compromise is in the best interests of the Fund and that such indemnitee appears to have acted in good faith in the reasonable belief that his action was in the best interest of the Fund and did not involve disabling conduct by such indemnitee and (3)&#160;with respect to any action, suit or other proceeding voluntarily prosecuted by any indemnitee as plaintiff, indemnification shall be mandatory only if the prosecution of such action, suit or other proceeding by such indemnitee was authorized by a majority of the full Board. Notwithstanding the foregoing the Fund shall not be obligated to provide any such indemnification to the extent such provision would waive any right which the Fund cannot lawfully waive. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">(b) The Fund will make advance payments in connection with the expenses of defending any action with respect to which indemnification might be sought hereunder if the Fund receives a written affirmation of the indemnitee&#8217;s good faith belief that the standard of conduct necessary for indemnification has been met and a written undertaking to reimburse the Fund unless it is subsequently determined that he is entitled to such indemnification and if the trustees of the Fund determine that the facts then known to them would not preclude indemnification. In addition, at least one of the following conditions must be met: (A)&#160;the indemnitee shall provide a security for his undertaking, (B)&#160;the Fund shall be insured against losses arising by reason of any lawful advances, or (C)&#160;a majority of a quorum of trustees of the Fund who are neither &#8220;interested persons&#8221; of the Fund (as defined in Section&#160;2(a)(19) of the </p>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Act) nor parties to the proceeding (&#8220;Disinterested <span style="white-space:nowrap">Non-Party</span> Trustees&#8221;) or an independent legal counsel in a written opinion, shall determine, based on a review of readily available facts (as opposed to a full trial-type inquiry), that there is reason to believe that the indemnitee ultimately will be found entitled to indemnification. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">(c) All determinations with respect to indemnification hereunder shall be made (1)&#160;by a final decision on the merits by a court or other body before whom the proceeding was brought that such indemnitee is not liable by reason of disabling conduct or, (2)&#160;in the absence of such a decision, by (i)&#160;a majority vote of a quorum of the Disinterested <span style="white-space:nowrap">Non-party</span> Trustees of the Fund, or (ii)&#160;if such a quorum is not obtainable or even, if obtainable, if a majority vote of such quorum so directs, independent legal counsel in a written opinion. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">The rights accruing to any indemnitee under these provisions shall not exclude any other right to which he may be lawfully entitled. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">Underwriter indemnification provisions to be filed by amendment. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">Additionally, the Registrant and the other funds in the Gabelli/GAMCO Fund Complex jointly maintain, at their own expense, E&amp;O/D&amp;O insurance policies for the benefit of its directors/trustees, officers and certain affiliated persons. The Registrant pays a pro rata portion of the premium on such insurance policies. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liability arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;31.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Business and Other Connections of Investment Adviser </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">The Investment Adviser, a limited liability company organized under the laws of the State of New York, acts as investment adviser to the Registrant. The Registrant is fulfilling the requirement of this Item&#160;31 to provide a list of the officers and directors of the Investment Adviser, together with information as to any other business, profession, vocation or employment of a substantial nature engaged in by the Investment Adviser or those officers and directors during the past two years, by incorporating by reference the information contained in the Form ADV of the Investment Adviser filed with the Securities and Exchange Commission pursuant to the Investment Advisers Act of 1940 (Securities and Exchange Commission File <span style="white-space:nowrap">No.&#160;801-37706).</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;32.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Location of Accounts and Records </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">The accounts and records of the Registrant are maintained in part at the office of the Investment Adviser at One Corporate Center, Rye, New York 10580-1422, in part at the offices of the Custodian, The Bank of New York Mellon, at 240 Greenwich Street, New York, NY 10286, in part at the offices of the transfer agent and registrar, American Stock Transfer&#160;&amp; Trust Company at 6201 15th Avenue, Brooklyn, NY 11219, and in part at the Fund&#8217;s <span style="white-space:nowrap">sub-administrator,</span> BNY Mellon Investment Servicing (US) Inc., at 760 Moore Road, King of Prussia, Pennsylvania 19406. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;33.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Management Services </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:11%; font-size:10pt; font-family:Times New Roman">Not applicable. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;34.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Undertakings </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">1.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">2.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">3.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Registrant undertakes: </p></td></tr></table>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">a.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to file, during a period in which offers or sales are being made, a post-effective amendment to this Registration Statement: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:18%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to include any prospectus required by Section&#160;10(a)(3) of the Securities Act; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:18%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to reflect in the prospectus any facts or events after the effective date of the registration statement (or the most recent post- effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:18%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:0%; font-size:10pt; font-family:Times New Roman">Provided, however, that paragraphs a(1), a(2), and a(3) of this section do not apply to the extent the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Exchange Act that are incorporated by reference into the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">b.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">that for the purpose of determining any liability under the Securities Act, each post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">c.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">d.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">that, for the purpose of determining liability under the Securities Act to any purchaser: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:18%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">if the Registrant is subject to Rule 430B: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:26%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(A)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:26%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(B)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (x), or (xi)&#160;for the purpose of providing the information required by Section&#160;10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:18%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">if the Registrant is subject to Rule 430C: each prospectus filed pursuant to Rule 424(b) under the Securities Act as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. </p></td></tr></table>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">e.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">that for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution of securities: </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">The undersigned Registrant undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to the purchaser: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:18%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule 424 under the Securities Act; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:18%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:18%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">the portion of any other free writing prospectus or advertisement pursuant to Rule 482 under the Securities Act relating to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:18%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">4.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not Applicable. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">5.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant&#8217;s annual report pursuant to Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934 that is incorporated by reference into the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">6.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">7.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Registrant undertakes to send by first class mail or other means designed to ensure equally prompt delivery, within two business days of receipt of a written or oral request, any prospectus or Statement of Additional Information. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">8.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Registrant undertakes to only offer rights to purchase common and preferred shares together after a post-effective amendment to the Registration Statement relating to such rights has been declared effective. </p></td></tr></table>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Rye, and State of New York, on the 24 day of August, 2022. </p> </div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:7%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">THE GDL FUND</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John C. Ball</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">John C. Ball</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">President </p></td></tr>
</table></div> </div> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities indicated and on the 24 day of August, 2022. </p> </div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:90%;border:0;margin-left:auto">


<tr>

<td style="width:38%"/>

<td style="vertical-align:bottom"/>
<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:16%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee, Chairman and Chief Investment Officer</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Mario J. Gabelli</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Anthony S. Colavita</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">James P. Conn</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Clarence A. Davis</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Leslie F. Foley</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Michael J. Melarkey</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Agnes Mullady</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Salvatore J. Zizza</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John C. Ball</p></td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:top" rowspan="2">President and Treasurer (Principal Executive, Financial and Accounting Officer)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">John C. Ball</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John C. Ball</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap"><span style="white-space:nowrap">Attorney-in-Fact</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">John C. Ball</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
</table></div> </div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pursuant to a Power of Attorney </p></td></tr></table>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EXHIBIT INDEX </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:7%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">EXHIBIT</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">NUMBER</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">DESCRIPTION OF EXHIBIT</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(b)(ii)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Amendment No. 1 to Amended and Restated By-Laws of Registrant</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(a)(iii)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Statement of Preferences for the Series E Cumulative Term Preferred Shares</td></tr>
</table> </div>
</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(A)(III)
<SEQUENCE>2
<FILENAME>d388267dex99aiii.htm
<DESCRIPTION>STATEMENT OF PREFERENCES FOR THE SERIES E CUMULATIVE TERM PREFERRED SHARES
<TEXT>
<HTML><HEAD>
<TITLE>Statement of Preferences for the Series E Cumulative Term Preferred Shares</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>THE GDL FUND </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>STATEMENT OF PREFERENCES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>SERIES E CUMULATIVE
TERM PREFERRED SHARES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">The GDL Fund, a Delaware statutory trust (the &#147;<U>Trust</U>&#148;), hereby certifies that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">FIRST: The Board of Trustees of the Trust (the &#147;<U>Board of Trustees</U>&#148;), at a meeting duly convened and held on February&nbsp;28, 2008 and
November&nbsp;19, 2008, pursuant to authority expressly vested in it by Article III of the Amended and Restated Agreement and Declaration of Trust, adopted resolutions classifying an unlimited amount of shares as authorized but unissued preferred
shares of the Trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">SECOND: The Board of Trustees, at a meeting duly convened and held on February&nbsp;8, 2022, approved the designation, issuance and
sale by the Trust of up to $40,000,000 in liquidation preference of Series E Cumulative Term Preferred Shares, par value $0.001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">THIRD: The
pricing committee of the Board of Trustees (the &#147;<U>Pricing Committee</U>&#148;), at a meeting duly convened and held on March&nbsp;28, 2022, approved the issuance and sale by the Trust of up to 3,500,000 shares of Series E Cumulative Term
Preferred Shares, par value $0.001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">FOURTH: The preferences, rights, voting powers, restrictions, limitations as to dividends and
distributions, qualifications, and terms and conditions of redemption of the Trust&#146;s<B> </B>Series E Cumulative Term Preferred Shares, par value $0.001&nbsp;per share, as set by the Board of Trustees and the Pricing Committee, are as follows:
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>DESIGNATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Series E Cumulative
Term Preferred Shares: A series of 3,500,000 preferred shares, par value $0.001&nbsp;per share, liquidation preference $10.00&nbsp;per share, is hereby designated &#147;Series E Cumulative Term Preferred Shares&#148; (the &#147;<U>Series E Preferred
Shares</U>&#148;). Each Series E Preferred Share may be issued on a date to be determined by the Board of Trustees or its delegatees and as are set forth in this Statement of Preferences; and shall have such other preferences, rights, voting powers,
restrictions, limitations as to dividends and distributions, qualifications and terms and conditions of redemption, in addition to those required by applicable law or set forth in the Governing Documents applicable to preferred shares of the Trust
(&#147;<U>Preferred Shares</U>&#148;), as are set forth in this Statement of Preferences. The Series E Preferred Shares shall constitute a separate series of Preferred Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">FIFTH: This Statement of Preferences sets forth the rights, powers, preferences and privileges of the holders of the Series E Preferred Shares and the
provisions set forth herein shall operate either as additions to or modifications of the rights, powers, preferences and privileges of the holders of the Series E Preferred Shares under the Declaration (as defined herein), as the context may
require. To the extent the provisions set forth herein conflict with the provisions of the Declaration with respect to any such rights, powers, preferences and privileges, this Statement of Preferences shall control. Except as contemplated by the
immediately preceding sentence, the Declaration shall control as to the Trust generally and the rights, powers, preferences and privileges of the other shareholders of the Trust. </P>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>PART I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Unless the context or use
indicates another or different meaning or intent, each of the following terms when used in this Statement of Preferences shall have the meaning ascribed to it below, whether such term is used in the singular or plural and regardless of tense: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>1940 Act</U>&#148; means the Investment Company Act of 1940, as amended, or any successor statute. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Adviser</U>&#148; means Gabelli Funds, LLC, a New York limited liability company, or such other Person as shall be serving as the investment adviser
of the Trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Asset Coverage</U>&#148; means asset coverage, as determined in accordance with Section&nbsp;18(h) of the 1940 Act, of at least
200% with respect to all outstanding senior securities of the Trust which are stock, including all Outstanding Series E Preferred Shares (or such other asset coverage as may in the future be specified in or under the 1940 Act as the minimum asset
coverage for senior securities which are stock of a <FONT STYLE="white-space:nowrap">closed-end</FONT> investment company as a condition of declaring dividends on its common stock), determined on the basis of values calculated as of a time within
48&nbsp;hours (not including Saturdays, Sundays or holidays) next preceding the time of such determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Board of Trustees</U>&#148; means
the Board of Trustees of the Trust or any duly authorized committee thereof as permitted by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means a day
on which the New York Stock Exchange is open for trading and that is neither a Saturday nor a Sunday. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">By-Laws</FONT></U>&#148; means the Amended and Restated <FONT STYLE="white-space:nowrap">By-Laws</FONT> of the
Trust, as amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Common Shares</U>&#148; means the common shares of beneficial interest, par value $0.001&nbsp;per share, of
the Trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Date of Original Issue</U>&#148; means March&nbsp;28, 2022 with respect to the Series E Preferred Shares, and for the purposes of
this Statement of Preferences shall have a correlative meaning with respect to any other class or series of Preferred Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Declaration</U>&#148; means the Agreement and Declaration of Trust of the Trust, dated as of November&nbsp;3, 2006, as amended, supplemented or
restated from time to time (including by this Statement of Preferences or by way of any other supplement or Statement of Preferences authorizing or creating a class of shares of beneficial interest in the Trust). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Deposit Assets</U>&#148; means cash, Short-Term Money Market Instruments and U.S.&nbsp;Government Obligations. Each Deposit Asset shall be deemed to
have a value equal to its principal or face amount payable at maturity plus any interest payable thereon after delivery of such Deposit Asset but only if payable on or prior to the applicable payment date in advance of which the relevant deposit is
made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Dividend-Disbursing Agent</U>&#148; means, with respect to the Series E Preferred Shares, Computershare Trust Company, N.A. and its
successors or any other dividend-disbursing agent appointed by the Trust and, with respect to any other class or series of Preferred Shares, the Person appointed by the Trust as dividend-disbursing or paying agent with respect to such class or
series. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Dividend Payment Date</U>&#148; means with respect to the Series E Preferred Shares, any date on which
dividends and distributions declared by, or under authority granted by, the Board of Trustees thereon are payable pursuant to the provisions of paragraph&nbsp;2(a) of Part&nbsp;II of this Statement of Preferences and shall for the purposes of this
Statement of Preferences have a correlative meaning with respect to any other class or series of Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Dividend Period</U>&#148;
shall have the meaning set forth in paragraph&nbsp;2(a) of Part II hereof, and for the purposes of this Statement of Preferences shall have a correlative meaning with respect to any other class or series of Preferred Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Governing Documents</U>&#148; means the Declaration and the <FONT STYLE="white-space:nowrap">By-Laws.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Liquidation Preference</U>&#148; shall, with respect to the Series E Preferred Shares, have the meaning set forth in paragraph&nbsp;3(a) of
Part&nbsp;II hereof, and for the purposes of this Statement of Preferences shall have a correlative meaning with respect to any other class or series of Preferred Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Notice of Redemption</U>&#148; shall have the meaning set forth in paragraph&nbsp;4(d)(i) of Part II hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Outstanding</U>&#148; means, as of any date, Preferred Shares theretofore issued by the Trust except: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(a)&nbsp;any such Preferred Shares theretofore redeemed, repurchased, cancelled or otherwise reacquired by the Trust or delivered to the Trust for redemption,
repurchase, cancellation or other acquisition by the Trust; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(b)&nbsp;any such Preferred Share as to which a Notice of Redemption shall have been given
and for whose payment at the redemption thereof Deposit Assets in the necessary amount are held by the Trust in trust for, or have been irrevocably deposited with the relevant disbursing agent for payment to, the holder of such share pursuant to
this Statement of Preferences with respect thereto; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(d)&nbsp;any such Preferred Share in exchange for or in lieu of which other shares have been
issued and delivered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Notwithstanding the foregoing, for purposes of voting rights (including the determination of the number of shares required to
constitute a quorum), any Preferred Shares as to which the Trust or any subsidiary of the Trust is the holder will be disregarded and deemed not Outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means and includes an individual, a partnership, the Trust, a trust, a corporation, a limited liability company, an unincorporated
association, a joint venture or other entity or a government or any agency or political subdivision thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Preferred Shares</U>&#148; means
all series of the preferred shares, par value $0.001&nbsp;per share, of the Trust, and includes the Series E Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Record
Date</U>&#148; shall have the meaning set forth in paragraph 2(a) of Part II hereof, and for the purposes of this Statement of Preferences shall have a correlative meaning with respect to any other class or series of Preferred Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Redemption</U><U></U><U>&nbsp;Price</U>&#148; has the meaning set forth in paragraph&nbsp;4(a) of Part II hereof, and for the purposes of this
Statement of Preferences shall have a correlative meaning with respect to any other class or series of Preferred Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Series E Preferred Shares</U>&#148; means the Series E Cumulative Term Preferred Shares, par value
$0.001&nbsp;per share, of the Trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Series E Asset Coverage Cure Date</U>&#148; means, with respect to the failure by the Trust to maintain
Asset Coverage (as required by paragraph&nbsp;6(a)(i) of Part II hereof) as of the last Business Day of each March, June, September and December of each year, 60&nbsp;days following such Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Short-Term Money Market Instruments</U>&#148; means the following types of instruments if, on the date of purchase or other acquisition thereof by
the Trust, the remaining term to maturity thereof is not in excess of 180 days: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(i)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">commercial paper rated <FONT STYLE="white-space:nowrap">A-1</FONT> if such commercial paper matures in 30 days or <FONT STYLE="white-space:nowrap">A-1+</FONT> if such commercial paper matures in over 30 days;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(ii)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">demand or time deposits in, and banker&#146;s acceptances and certificates of deposit of (A)&nbsp;a depository institution or trust company incorporated under the laws of the United States of America or any state thereof or the
District of Columbia or (B)&nbsp;a United States branch office or agency of a foreign depository institution (provided that such branch office or agency is subject to banking regulation under the laws of the United States, any state thereof or the
District of Columbia);</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(iii)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">overnight funds; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(iv)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">U.S. Government Obligations.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Trust</U>&#148; means The GDL Fund, a Delaware statutory trust. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>U.S. Government Obligations</U>&#148; means direct obligations of the United States or obligations issued by its agencies or instrumentalities that
are entitled to the full faith and credit of the United States and that, other than United States Treasury Bills, provide for the periodic payment of interest and the full payment of principal at maturity or call for redemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">&#147;<U>Voting Period</U>&#148; shall have the meaning set forth in paragraph&nbsp;5(b) of Part II hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>SERIES E CUMULATIVE TERM PREFERRED SHARES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">1. Number of Shares; Ranking. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(a) The initial number of
authorized Shares constituting the Series E Preferred Shares to be issued is 3,500,000. No fractional Series E Preferred Shares shall be issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(b)
Series E Preferred Shares which at any time have been redeemed or purchased by the Trust shall, after such redemption or purchase, have the status of authorized but unissued Preferred Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(c) The Series E Preferred Shares shall rank on a parity with any other series of Preferred Shares as to the payment of dividends, distributions and
liquidation preference to which such Shares are entitled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(d) No holder of Series E Preferred Shares shall have, solely by reason of being such a holder,
any preemptive or other right to acquire, purchase or subscribe for any Preferred Shares or Common Shares or other securities of the Trust which it may hereafter issue or sell. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">2. Dividends and Distributions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(a) Holders of Series E
Preferred Shares shall be entitled to receive, when, as and if declared by, or under authority granted by, the Board of Trustees, out of funds legally available therefor, cumulative cash dividends and distributions, calculated separately for each
dividend period, payable quarterly on March&nbsp;26, June&nbsp;26, September&nbsp;26&nbsp;and December&nbsp;26&nbsp;in each year (each a &#147;<U>Dividend Payment Date</U>&#148;) commencing on the Dividend Payment Date following the Date of Original
Issue (if any Dividend Payment Date is not a Business Day, then on the next succeeding Business Day), and computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve
<FONT STYLE="white-space:nowrap">30-day</FONT> months, of the Liquidation Preference on the Series E Preferred Shares. As used herein, each period beginning on and including a Dividend Payment Date (or beginning on the Date of Original Issue, in the
case of the first dividend period after the issuance of such Series E Preferred Shares) and ending on but excluding the next succeeding Dividend Payment Date is referred to as a &#147;Dividend Period.&#148; The Dividend Period beginning on the Date
of Original Issue, together with the next three Dividend Periods, are referred to herein as &#147;Year 1.&#148; For Dividend Periods occurring in Year 1, dividends will be paid at an annualized rate of 4.00% based on the Liquidation Preference of
the Series E Preferred Shares. For the Dividend Periods occurring after Year 1, dividends will be paid at an annualized rate of 4.25% based on the Liquidation Preference of the Series E Preferred Shares. Dividends and distributions will be payable
to holders of record of Series E Preferred Shares as they appear on the share register of the Trust at the close of business on the fifth Business Day preceding the Dividend Payment Date (each, a &#147;<U>Record Date</U>&#148;) in preference to
dividends and distributions on Common Shares and any other capital shares of the Trust ranking junior to the Series E Preferred Shares in payment of dividends and distributions. Dividends and distributions on Series E Preferred Shares that were
originally issued on the Date of Original Issue shall accumulate from the Date of Original Issue. Dividends and distributions on all other Series E Preferred Shares shall accumulate from (i)&nbsp;the date on which such shares are originally issued
if such date is a Dividend Payment Date, (ii)&nbsp;the immediately preceding Dividend Payment Date if the date on which such shares are originally issued is other than a Dividend Payment Date and is on or before a Record Date or (iii)&nbsp;the
immediately following Dividend Payment Date if the date on which such shares are originally issued is during the period between a Record Date and a Dividend Payment Date. Dividends and distributions on account of arrears for any past Dividend Period
or in connection with the redemption of Series E Preferred Shares may be declared and paid at any time, without reference to any Dividend Payment Date, to holders of record on such date not exceeding 30&nbsp;days preceding the payment date thereof
as shall be fixed by the Board of Trustees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(b)&nbsp;(i)&nbsp;No full dividends or distributions shall be declared or paid on Series E Preferred Shares for
any Dividend Period or part thereof unless full cumulative dividends and distributions due through the most recent Dividend Payment Dates therefor for all series of Preferred Shares ranking on a parity with the Series E Preferred Shares as to the
payment of dividends and distributions have been or contemporaneously are declared and paid through the most recent Dividend Payment Dates therefor. If full cumulative dividends and distributions due have not been paid on all such Outstanding
Preferred Shares, any dividends and distributions being paid on such Preferred Shares (including the Series E Preferred Shares) will be paid as nearly pro rata as possible in proportion to the respective amounts of dividends and distributions
accumulated but unpaid on each such series of Preferred Shares on the relevant Dividend Payment Date. No holders of Series E Preferred Shares shall be entitled to any dividends or distributions, whether payable in cash, property or shares, in excess
of full cumulative dividends and distributions as provided in this paragraph&nbsp;2(b)(i) on Series E Preferred Shares. No interest or sum of money in lieu of interest shall be payable in respect of any dividend payments on any Series E Preferred
Shares that may be in arrears. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(ii)&nbsp;For so long as Series E Preferred Shares are Outstanding, the Trust shall not pay any dividend or other
distribution (other than a dividend or distribution paid in Common Shares, or options, warrants or rights to subscribe for or purchase Common Shares or other shares, if any, ranking junior to the Series E Preferred Shares as to payment of dividends
and the distribution of assets upon liquidation) in respect of the Common Shares or any other shares of the Trust ranking junior to the Series E Preferred Shares as to the payment of dividends and the distribution of assets upon liquidation, or call
for redemption, redeem, purchase or otherwise acquire for consideration any Common Shares or any other shares of the Trust ranking junior to the Series E Preferred Shares as to the payment of dividends and the distribution of assets upon liquidation
(except by conversion into or exchange for shares of the Trust ranking junior to the Series E Preferred Shares as to payment of dividends and the distribution of assets upon liquidation), unless, in each case, (A)&nbsp;immediately thereafter, the
Trust shall have Asset Coverage, (B)&nbsp;all cumulative dividends and distributions on all Series E Preferred Shares due on or prior to the date of the transaction have been declared and paid (or shall have been declared and sufficient funds for
the payment thereof deposited with the applicable Dividend-Disbursing Agent) and (C)&nbsp;the Trust has redeemed the full number of Series E Preferred Shares to be redeemed mandatorily pursuant to any provision contained herein for mandatory
redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(iii)&nbsp;Any dividend payment made on the Series E Preferred Shares shall first be credited against the dividends and distributions
accumulated with respect to the earliest Dividend Period for which dividends and distributions have not been paid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(c) Not later than the Business Day
immediately preceding each Dividend Payment Date, the Trust shall deposit with the Dividend-Disbursing Agent Deposit Assets having an initial combined value sufficient to pay the dividends and distributions that are payable on such Dividend Payment
Date, which Deposit Assets shall mature (if such assets constitute debt securities or time deposits) on or prior to such Dividend Payment Date. The Trust may direct the Dividend-Disbursing Agent with respect to the investment of any such Deposit
Assets, provided that such investment consists exclusively of Deposit Assets and provided further that the proceeds of any such investment will be available at the opening of business on such Dividend Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">3. Liquidation Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(a) In the event of any liquidation,
dissolution or winding up of the affairs of the Trust, whether voluntary or involuntary, the holders of Series E Preferred Shares shall be entitled to receive out of the assets of the Trust available for distribution to shareholders, after
satisfying claims of creditors but before any distribution or payment shall be made in respect of the Common Shares or any other shares of the Trust </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">
ranking junior to the Series E Preferred Shares as to liquidation payments, a liquidation distribution in the amount of $10.00&nbsp;per share (the &#147;<U>Liquidation Preference</U>&#148;), plus
an amount equal to all unpaid dividends and distributions accumulated to and including the date fixed for such distribution or payment (whether or not earned or declared by the Trust, but excluding interest thereon), and such holders shall be
entitled to no further participation in any distribution or payment in connection with any such liquidation, dissolution or winding up of the Trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(b)
If, upon any liquidation, dissolution or winding up of the affairs of the Trust, whether voluntary or involuntary, the assets of the Trust available for distribution among the holders of all Outstanding Series E Preferred Shares, and any other
Outstanding class or series of Preferred Shares ranking on a parity with the Series E Preferred Shares as to payment upon liquidation, shall be insufficient to permit the payment in full to such holders of Series E Preferred Shares of the
Liquidation Preference plus accumulated and unpaid dividends and distributions and the amounts due upon liquidation with respect to such other Preferred Shares, then such available assets shall be distributed among the holders of Series E Preferred
Shares and such other Preferred Shares ratably in proportion to the respective preferential liquidation amounts to which they are entitled. Notwithstanding any other provision of this Statement of Preferences, Series E Preferred Shares submitted for
redemption pursuant to paragraph 4(c) hereof will remain subject to the foregoing liquidation terms until the applicable redemption date. Unless and until the Liquidation Preference plus accumulated and unpaid dividends and distributions has been
paid in full to the holders of Series E Preferred Shares, no dividends or distributions will be made to holders of the Common Shares or any other shares of the Trust ranking junior to the Series E Preferred Shares as to liquidation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">4. Redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">The Series E Preferred Shares shall be redeemed
by the Trust as provided below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(a) Mandatory Redemptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">The Trust is required to redeem the Series E Preferred Shares on March&nbsp;26, 2025 at a price equal to the Liquidation Preference plus accumulated but
unpaid dividends and distributions (whether or not earned or declared by the Trust) to, but not including, the date of redemption (the &#147;<U>Redemption Price</U>&#148;). If the Trust is required to redeem any Preferred Shares (which may include
Series E Preferred Shares) prior to March&nbsp;26, 2025 pursuant to paragraph&nbsp;6(b) of Part II hereof, then the Trust shall, to the extent permitted by the 1940 Act and Delaware law, by the close of business on such Series E Asset Coverage Cure
Date, fix a redemption date and proceed to redeem shares as set forth in paragraph&nbsp;4(d) hereof. On such redemption date, the Trust shall redeem, out of funds legally available therefor, (i)&nbsp;the number of Preferred Shares, which, to the
extent permitted by the 1940 Act and Delaware law, at the option of the Trust may include any proportion of Series E Preferred Shares or any other series of Preferred Shares, equal to the minimum number of shares the redemption of which, if such
redemption had occurred immediately prior to the opening of business on such Series E Asset Coverage Cure Date, would have resulted in the Trust having Asset Coverage immediately prior to the opening of business on such Series E Asset Coverage Cure
Date or (ii)&nbsp;if such Asset Coverage cannot be so restored, all of the Outstanding Series E Preferred Shares, at a price equal to the Redemption Price. In the event that Preferred Shares are redeemed pursuant to paragraph&nbsp;6(b) Part II
hereof, the Trust may, but is not required to, redeem an additional number of Series E Preferred Shares pursuant to this paragraph&nbsp;4(a) which, when aggregated with other Preferred Shares redeemed by the Trust, permits the Trust to have with
respect to the Preferred Shares (including the Series E Preferred Shares) remaining Outstanding after such redemption Asset Coverage of as much as 220%. In the event that all of the Series E Preferred Shares then Outstanding are required to be
redeemed pursuant to paragraph&nbsp;6 of Part II hereof, the Trust shall redeem such shares at the Redemption&nbsp;Price and proceed to do so as set forth in paragraph&nbsp;4(d) hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(b)&nbsp;Optional Redemptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">The Trust may, upon Notice of Redemption, redeem the Series E Preferred Shares in whole or in part at the Redemption&nbsp;Price per share on March&nbsp;26,
2024. The Series E Preferred Shares are not otherwise subject to optional redemption by the Trust unless such redemption is necessary, in the judgment of the Board of Trustees, to maintain the Trust&#146;s status as a regulated investment company
under Subchapter M of the Internal Revenue Code of 1986, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(c) Holder Put Options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">The Trust will redeem all or any part of the Series E Preferred Shares that holders have properly tendered for redemption during the <FONT
STYLE="white-space:nowrap">60-day</FONT> period prior to each of March&nbsp;26, 2023 and March&nbsp;26, 2024 at the Redemption Price per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(d)&nbsp;Procedures for Redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(i)&nbsp;If the Trust
shall determine or be required to redeem Series E Preferred Shares pursuant to paragraph&nbsp;4(a) or paragraph 4(b) of this Part II, it shall mail a written notice of redemption (&#147;<U>Notice of Redemption</U>&#148;) with respect to such
redemption by first class mail, postage prepaid, to each holder of the shares to be redeemed at such holder&#146;s address as the same appears on the share register of the Trust on the close of business on such date as the Board of Trustees or its
delegatee may determine, which date shall not be earlier than the second Business Day prior to the date upon which such Notice of Redemption is mailed to the holders of Series E Preferred Shares. Each such Notice of Redemption shall state:
(A)&nbsp;the redemption date as established by the Board of Trustees or its delegatee; (B)&nbsp;the number or percentage of Series E Preferred Shares to be redeemed; (C)&nbsp;the CUSIP number(s) of such shares; (D)&nbsp;the Redemption&nbsp;Price
(specifying the amount of accumulated dividends and distributions to be included therein); (E)&nbsp;the place or places where the certificate(s) for such shares (properly endorsed or assigned for transfer, if the Board of Trustees or its delegatee
shall so require and the Notice of Redemption shall so state), if any, are to be surrendered for payment in respect of such redemption; (F)&nbsp;that dividends and distributions on the shares to be redeemed will cease to accrue on such redemption
date; (G)&nbsp;the provisions of this paragraph&nbsp;4 under which such redemption is made; and (H)&nbsp;in the case of a redemption pursuant to paragraph&nbsp;4(b), any conditions precedent to such redemption. If fewer than all Series E Preferred
Shares held by any holder are to be redeemed, the Notice of Redemption mailed to such holder also shall specify the number or percentage of shares to be redeemed from such holder. No defect in the Notice of Redemption or the mailing thereof shall
affect the validity of the redemption proceedings, except as required by applicable law. The Notice of Redemption shall be mailed to the holders of Series E Preferred Shares to be redeemed not fewer than 15 days nor more than 40 days prior to the
date fixed for redemption; provided, however, that shorter notice may be given in the case of a redemption pursuant to paragraph 4(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(ii)&nbsp;If the
Trust shall give a Notice of Redemption, then by the close of business on the Business Day preceding the redemption date specified in the Notice of Redemption (so long as any conditions precedent to such redemption have been met) or, if the
Dividend-Disbursing Agent so agrees, another date not later than the redemption date, the Trust shall (A)&nbsp;deposit with the Dividend-Disbursing Agent Deposit Assets that shall mature (if such assets constitute debt securities or time deposits)
on or prior to such redemption date having an initial combined value sufficient to effect the redemption of the Series E Preferred Shares to be redeemed and (B)&nbsp;give the Dividend-Disbursing Agent irrevocable instructions and authority to pay
the Redemption&nbsp;Price to the holders of the Series E Preferred Shares called for redemption on the redemption date. The Trust may direct the Dividend-Disbursing Agent with respect to the investment of any Deposit Assets so deposited provided
that the proceeds of any such investment will be available at the opening of business on such redemption date. Upon the date of such deposit (unless the Trust shall default </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">
in making payment of the Redemption&nbsp;Price), all rights of the holders of the Series E Preferred Shares so called for redemption shall cease and terminate except the right of the holders
thereof to receive the Redemption&nbsp;Price thereof and such shares shall no longer be deemed Outstanding for any purpose. The Trust shall be entitled to receive, promptly after the date fixed for redemption, any cash in excess of the aggregate
Redemption Price of the Series E Preferred Shares called for redemption on such date and any remaining Deposit Assets. Any assets so deposited that are unclaimed at the end of two years from such redemption date shall, to the extent permitted by
law, be repaid to the Trust, after which the holders of the Series E Preferred Shares so called for redemption shall look only to the Trust for payment of the Redemption&nbsp;Price thereof. The Trust shall be entitled to receive, from time to time
after the date fixed for redemption, any interest on the Deposit Assets so deposited. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(iii)&nbsp;On or after the redemption date, each holder of Series E
Preferred Shares that are subject to redemption shall surrender such shares to the Trust as instructed in the Notice of Redemption and shall then be entitled to receive the cash Redemption&nbsp;Price, without interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(iv)&nbsp;In the case of any redemption of less than all of the Series E Preferred Shares pursuant to this Statement of Preferences, such redemption shall be
made pro rata from each holder of Series E Preferred Shares in accordance with the respective number of shares held by each such holder on the record date for such redemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(v)&nbsp;Notwithstanding the other provisions of this paragraph&nbsp;4, the Trust shall not redeem any Series E Preferred Shares unless all accumulated and
unpaid dividends and distributions on all Outstanding Series E Preferred Shares and other Preferred Shares ranking on a parity with the Series E Preferred Shares with respect to dividends and distributions for all applicable past Dividend Periods
(whether or not earned or declared by the Trust) shall have been or are contemporaneously paid or declared and Deposit Assets for the payment of such dividends and distributions shall have been deposited with the Dividend-Disbursing Agent as set
forth in paragraph&nbsp;2(c) of Part II hereof, provided, however, that the foregoing shall not prevent the purchase or acquisition of Outstanding Preferred Shares pursuant to the successful completion of an otherwise lawful purchase or exchange
offer made on the same terms to holders of all Outstanding Series E Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">If the Trust shall not have funds legally available for the
redemption of, or is otherwise unable to redeem, all the Series E Preferred Shares or other Preferred Shares designated to be redeemed on any redemption date, the Trust shall redeem on such redemption date the number of Series E Preferred Shares and
other Preferred Shares so designated as it shall have legally available funds, or is otherwise able, to redeem ratably on the basis of the Redemption&nbsp;Price from each holder whose shares are to be redeemed, and the remainder of the Series E
Preferred Shares and other Preferred Shares designated to be redeemed shall be redeemed on the earliest practicable date on which the Trust shall have funds legally available for the redemption of, or is otherwise able to redeem, such shares upon
Notice of Redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">5.&nbsp;Voting Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(a)&nbsp;General. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Except as otherwise provided in the
Governing Documents or a resolution of the Board of Trustees, or as required by applicable law, holders of Series E Preferred Shares shall have no power to vote on any matter except matters submitted to a vote of the Common Shares. In any matter
submitted to a vote of the holders of the Common Shares, each holder of Series E Preferred Shares shall be entitled to one vote for each Series E Preferred Share held and the holders of the Outstanding Preferred Shares, including Series E Preferred
Shares, and the Common Shares shall vote together as a single class; provided, however, that the holders of the Outstanding Preferred Shares, including Series E Preferred Shares, shall be entitled, as
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">
a separate class, to the exclusion of the holders of all other securities and classes of capital shares of the Trust, to elect two of the Trust&#146;s trustees. Subject to paragraph&nbsp;5(b) of
Part II hereof, the holders of the outstanding capital shares of the Trust, including the holders of the Outstanding Preferred Shares, including the Series E Preferred Shares, voting as a single class, shall elect the balance of the trustees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(b)&nbsp;Right to Elect Majority of Board of Trustees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">During
any period in which any one or more of the conditions described below shall exist (such period being referred to herein as a &#147;<U>Voting Period</U>&#148;), the number of trustees constituting the Board of Trustees shall be automatically
increased by the smallest number that, when added to the two trustees elected exclusively by the holders of Preferred Shares pursuant to paragraph 5(a) above, would constitute a majority of the Board of Trustees as so increased by such smallest
number; and the holders of Preferred Shares shall be entitled, voting separately as one class (to the exclusion of the holders of all other securities and classes of shares of the Trust), to elect such smallest number of additional trustees,
together with the two trustees that such holders are in any event entitled to elect pursuant to paragraph 5(a) above. The Trust and the Board of Trustees shall take all necessary action, including amending the
<FONT STYLE="white-space:nowrap">By-Laws,</FONT> to effect an increase in the number of trustees as described in the preceding sentence. A Voting Period shall commence: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(i)&nbsp;if at any time accumulated dividends and distributions (whether or not earned or declared, and whether or not funds are then legally available in an
amount sufficient therefor) on the Outstanding Series E Preferred Shares equal to at least two full years&#146; dividends and distributions shall be due and unpaid and sufficient Deposit Assets shall not have been deposited with the
Dividend-Disbursing Agent for the payment of such accumulated dividends and distributions;&nbsp;or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(ii)&nbsp;if at any time holders of any other
Preferred Shares are entitled to elect a majority of the trustees of the Trust under the 1940 Act or Statement of Preferences creating such shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Upon
the termination of a Voting Period, the voting rights described in this paragraph&nbsp;5(b) shall cease, subject always, however, to the reverting of such voting rights in the holders of Preferred Shares upon the further occurrence of any of the
events described in this paragraph&nbsp;5(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(c)&nbsp;Voting Procedures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(i)&nbsp;As soon as practicable after the accrual of any right of the holders of Preferred Shares to elect additional trustees as described in
paragraph&nbsp;5(b) above, the Trust shall call a special meeting of such holders and shall mail a notice of such special meeting to such holders, such meeting to be held not less than 10 nor more than 20&nbsp;days after the date of mailing of such
notice. If the Trust fails to send such notice or if the Trust does not call such a special meeting, it may be called by any such holder on like notice. The record date for determining the holders entitled to notice of and to vote at such special
meeting shall be the close of business on the day on which such notice is mailed or such other date as the Board of Trustees shall determine. At any such special meeting and at each meeting held during a Voting Period, such holders of Preferred
Shares, voting together as a class (to the exclusion of the holders of all other securities and classes of capital shares of the Trust), shall be entitled to elect the number of trustees prescribed in paragraph&nbsp;5(b) above on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-vote-per-share</FONT></FONT></FONT> basis. At any such meeting, or adjournment thereof in the absence of a quorum, a majority of such holders present in
person or by proxy shall have the power to adjourn the meeting without notice, other than by an announcement at the meeting, to a date not more than 120&nbsp;days after the original record date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(ii)&nbsp;For purposes of determining any rights of the holders of Series E Preferred Shares to vote on any matter or the number of shares required to
constitute a quorum, whether such right is created by this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">
Statement of Preferences, by the other provisions of the Governing Documents, by statute or otherwise, any Series E Preferred Share which is not Outstanding shall not be counted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(iii)&nbsp;The terms of office of all persons who are trustees of the Trust at the time of a special meeting of holders of Preferred Shares, including Series
E Preferred Shares, to elect trustees, shall continue following such meeting, notwithstanding the election at such meeting by such holders of the number of trustees that they are entitled to elect, and the persons so elected by such holders,
together with the two incumbent trustees elected by the holders of Preferred Shares, including Series E Preferred Shares, and the remaining incumbent trustees elected by the holders of the Common Shares and Preferred Shares, shall constitute the
duly elected trustees of the Trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(iv)&nbsp;Upon the expiration of a Voting Period, the terms of office of the additional trustees elected by the
holders of Preferred Shares pursuant to paragraph&nbsp;5(b) above shall expire at the earliest time permitted by law and the remaining trustees shall constitute the trustees of the Trust and the voting rights of such holders of Preferred Shares,
including Series E Preferred Shares, to elect additional trustees pursuant to paragraph&nbsp;5(b) above shall cease, subject to the provisions of the last sentence of paragraph&nbsp;5(b). Upon the expiration of the terms of the trustees elected by
the holders of Preferred Shares pursuant to paragraph&nbsp;5(b) above, the number of trustees shall be automatically reduced to the number and composition of trustees on the Board immediately preceding such Voting Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(e)&nbsp;Exclusive Remedy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Unless otherwise required by law,
the holders of Series E Preferred Shares shall not have any rights or preferences other than those specifically set forth herein. The holders of Series E Preferred Shares shall have no preemptive rights or rights to cumulative voting. In the event
that the Trust fails to pay any dividends and distributions on the Series E Preferred Shares, or fails to complete any voluntary or mandatory redemption, the exclusive remedy of the holders shall be the right to vote for trustees pursuant to the
provisions of this paragraph&nbsp;5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">6.&nbsp;Coverage Tests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(a)&nbsp;Determination of Compliance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">For so long as any
Series E Preferred Shares are Outstanding, the Trust shall make the following determinations: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(i)&nbsp;Asset Coverage. The Trust shall have Asset
Coverage as of the last Business Day of each March, June, September and December of each year in which any Series E Preferred Shares are Outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(b)&nbsp;Failure to Meet Asset Coverage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">If the Trust fails to
have Asset Coverage as provided in paragraph&nbsp;6(a)(i) hereof and such failure is not cured as of the Series E Asset Coverage Cure Date, (i)&nbsp;the Trust shall give a Notice of Redemption as described in paragraph&nbsp;4 of Part II hereof with
respect to the redemption of a sufficient number of Preferred Shares, which at the Trust&#146;s determination (to the extent permitted by the 1940 Act and Delaware law) may include any proportion of Series E Preferred Shares, to enable it to meet
the requirements of paragraph&nbsp;6(a)(i) above, and, at the Trust&#146;s discretion, such additional number of Series E Preferred Shares or other Preferred Shares in order that the Trust have Asset Coverage with respect to the Series E Preferred
Shares and any other Preferred Shares remaining Outstanding after such redemption as great as 220%, and (ii)&nbsp;deposit with the Dividend-Disbursing Agent Deposit Assets having an initial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">
combined value sufficient to effect the redemption of the Series E Preferred Shares or other Preferred Shares to be redeemed, as contemplated by paragraph&nbsp;4 of Part II hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(c)&nbsp;Status of Shares&nbsp;Called for Redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">For
purposes of determining whether the requirements of paragraph&nbsp;6(a)(i) hereof are satisfied, (i)&nbsp;no Series E Preferred Share shall be deemed to be Outstanding for purposes of any computation if, prior to or concurrently with such
determination, sufficient Deposit Assets to pay the full Redemption&nbsp;Price for such share shall have been deposited in trust with the Dividend-Disbursing Agent (or applicable paying agent) and the requisite Notice of Redemption shall have been
given, and (ii)&nbsp;such Deposit Assets deposited with the Dividend-Disbursing Agent (or paying agent) shall not be included. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">7.&nbsp;Limitation on
Incurrence of Additional Indebtedness and Issuance of Additional Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(a)&nbsp;So long as any Series E Preferred Shares are Outstanding and
the Trust is permitted to issue indebtedness under its fundamental investment restrictions, the Trust may issue and sell one or more series of a class of senior securities of the Trust representing indebtedness under Section&nbsp;18 of the 1940 Act
and/or otherwise create or incur indebtedness, provided that, immediately after giving effect to the incurrence of such indebtedness and to its receipt and application of the proceeds thereof, the Trust shall have an &#147;asset coverage&#148; for
all senior securities representing indebtedness, as defined in Section&nbsp;18(h) of the 1940 Act, of at least 300% of the amount of all indebtedness of the Trust then Outstanding and no such additional indebtedness shall have any preference or
priority over any other indebtedness of the Trust upon the distribution of the assets of the Trust or in respect of the payment of interest. Any possible liability resulting from lending and/or borrowing portfolio securities, entering into reverse
repurchase agreements, entering into futures contracts and writing options or the use of any other financial instrument that may have the effect of creating leverage but is not considered a senior security representing indebtedness under the 1940
Act, to the extent such transactions are made in accordance with the investment restrictions of the Trust then in effect, shall not be considered to be indebtedness limited by this paragraph 7(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(b)&nbsp;So long as any Series E Preferred Shares are Outstanding, the Trust may issue and sell shares of one or more other series of Preferred Shares
constituting a series of a class of senior securities of the Trust representing stock under Section&nbsp;18 of the 1940 Act in addition to the Series E Preferred Shares and other Preferred Shares then Outstanding, provided that (i)&nbsp;the Trust
shall, immediately after giving effect to the issuance of such additional Preferred Shares and to its receipt and application of the proceeds thereof, including, without limitation, to the redemption of Preferred Shares for which a Notice of
Redemption&nbsp;has been mailed prior to such issuance, have an &#147;asset coverage&#148; for all senior securities which are stock, as defined in Section&nbsp;18(h) of the 1940 Act, of at least 200% of the sum of the Liquidation Preference of the
Series E Preferred Shares and all other Preferred Shares then Outstanding, and (ii)&nbsp;no such additional Preferred Shares shall have any preference or priority over any other Preferred Shares upon liquidation or the distribution of the assets of
the Trust or in respect of the payment of dividends. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">8. Treatment of Series E Preferred Shares for Tax Purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Unless otherwise required by law, the holders of the Series E Preferred Shares shall treat Series E Preferred Shares as equity of the Trust for all U.S.
federal, local and other income tax purposes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>PART&nbsp;III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>ABILITY OF THE BOARD OF TRUSTEES TO MODIFY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>THE STATEMENT OF PREFERENCES </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">1.
Modification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(a) So long as any Series E Preferred Shares are Outstanding, the Trust shall not amend, alter or repeal the provisions of this Statement
of Preferences so as to in the aggregate materially and adversely affect the rights and preferences set forth in any Statement of Preferences, including those of the Series E Preferred Shares, without the affirmative vote of the holders of a
majority (as defined in the 1940 Act) of the Preferred Shares Outstanding at the time and present and voting on such matter, voting separately as one class. To the extent permitted under the 1940 Act, in the event that more than one series of
Preferred Shares is Outstanding, the Trust shall not effect any of the actions set forth in the preceding sentence which in the aggregate materially and adversely affects the rights and preferences set forth in the Statement of Preferences for a
series of Preferred Shares differently than such rights and preferences for any other series of Preferred Shares without the affirmative vote of the holders of at least a majority of the Preferred Shares Outstanding and present and voting on such
matter of each series materially and adversely affected (each such materially and adversely affected series voting separately as a class to the extent its rights are affected differently). The holders of the Series E Preferred Shares shall not be
entitled to vote on any matter that affects the rights or interests of only one or more other series of Preferred Shares. Unless a higher percentage is required under the Governing Documents or applicable provisions of the Delaware Statutory Trust
Act or the 1940 Act, the affirmative vote of the holders of a majority of the Outstanding Preferred Shares, including Series E Preferred Shares, voting together as a single class, will be required to approve any plan of reorganization adversely
affecting the Preferred Shares or any action requiring a vote of security holders under Section&nbsp;13(a) of the 1940 Act. For purposes of this paragraph 1(a) of Part III, the phrase &#147;vote of the holders of a majority of the Outstanding
Preferred Shares&#148; or series or series thereof (or any like phrase) shall mean, in accordance with Section&nbsp;2(a)(42) of the 1940 Act, the vote, at the annual or a special meeting of the shareholders of the Trust duly called (i)&nbsp;of
67&nbsp;percent or more of the Preferred Shares or series thereof present at such meeting, if the holders of more than 50&nbsp;percent of the Outstanding Preferred Shares or series thereof are present or represented by proxy; or (ii)&nbsp;of more
than 50&nbsp;percent of the Outstanding Preferred Shares or series thereof, whichever is less. The class vote of holders of Preferred Shares described above will in each case be in addition to a separate vote of the requisite percentage of Common
Shares and Preferred Shares, including Series E Preferred Shares, voting together as a single class, necessary to authorize the action in question. An increase in the number of authorized Preferred Shares pursuant to the Governing Documents or the
issuance of additional shares of any series of Preferred Shares (including Series E Preferred Shares) pursuant to the Governing Documents shall not in and of itself be considered to materially and adversely affect the rights and preferences of
Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">(b) Notwithstanding the provisions of this Part III, to the extent permitted by law, the Board of Trustees or its delegatee, without
the vote of the holders of the Series E Preferred Shares or any other capital shares of the Trust, may amend the provisions of this Statement of Preferences to resolve any inconsistency or ambiguity or to remedy any formal defect so long as the
amendment does not in the aggregate adversely affect the rights and preferences of the Series E Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">2. No Modification of Other Series of
Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Nothing contained in this Statement of Preferences creating the Series E Preferred Shares shall be understood to modify the rights,
obligations or privileges of any other series of the Trust&#146;s Preferred Shares Outstanding. To the extent permitted by law, the Board of Trustees, without the vote of the holders </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">
of the Series E Preferred Shares or any other shares of the Trust, may amend the provisions of this Statement of Preferences to resolve any inconsistency or ambiguity or to remedy any formal
defect so as to negate the effect of any such modification of the rights, obligations or privileges of any other series of the Trust&#146;s Preferred Shares Outstanding, so long as the amendment does not in the aggregate adversely affect the rights
and preferences of the Series E Preferred Shares. </P> <P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">IN WITNESS WHEREOF, The GDL Fund has caused this Statement of Preferences to be signed in its name and on its
behalf by a duly authorized officer, who acknowledges said instrument to be the statutory trust act of the Trust, and states that, to the best of such officer&#146;s knowledge, information and belief under penalty of perjury, the matters and facts
herein set forth with respect to approval are true in all material respects, as of March [ ], 2022. </P> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top">Attest:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top">Title:</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><I>[GDL Series E Statement of Preferences Signature Page</I>] </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99. (B)(II)
<SEQUENCE>3
<FILENAME>d388267dex99bii.htm
<DESCRIPTION>AMENDMENT NO. 1 TO THE AMENDED AND RESTATED BY-LAWS OF REGISTRANT
<TEXT>
<HTML><HEAD>
<TITLE>Amendment No. 1 to the Amended and Restated By-Laws of Registrant</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 1 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>TO </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED <FONT
STYLE="white-space:nowrap">BY-LAWS</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>THE GDL FUND </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Effective:
August&nbsp;17, 2022 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">On August&nbsp;17, 2022, the Board of Trustees of The GDL Fund (the &#147;Fund&#148;), in accordance with the Fund&#146;s
Amended and Restated <FONT STYLE="white-space:nowrap">By-Laws</FONT> (the <FONT STYLE="white-space:nowrap">&#147;By-Laws&#148;)</FONT> and Amended and Restated Agreement and Declaration of Trust, approved and adopted the following amendment to the <FONT
STYLE="white-space:nowrap">By-Laws,</FONT> to be effective immediately: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">Article I, Section&nbsp;1.2 of the
<FONT STYLE="white-space:nowrap">By-Laws</FONT> is hereby deleted in its entirety and replaced with the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">Section&nbsp;1.2
Voting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As provided in the Declaration, shareholders shall have no power to vote on
any matter except as provided in or pursuant to Section&nbsp;6.2 of the Declaration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As provided in Section&nbsp;6.4(b) of the Declaration, where a separate vote of one or more
classes or series of Shares is required on any matter: (i)&nbsp;if the vote is for the election of one or more Trustees, the vote set forth in Section&nbsp;1.2(c), below, shall apply in respect of the classes or series of Shares entitled to vote in
the election of such Trustee or Trustees; and (ii)&nbsp;if the vote is for any other matter, the affirmative vote of a majority of the Shares of such class or classes or series or series present in person or represented by proxy and entitled to vote
on such other matter shall be the act of the shareholders of such class or classes or series or series with respect to such other matter, in each case at any meeting at which a quorum is present with respect to the vote on the election of such
Trustee(s) or such other matter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As provided in Section&nbsp;6.4(b) of the
Declaration, with respect to the election of one or more Trustees, (i)&nbsp;other than a Contested Election, the affirmative vote of a plurality of the Shares present in person or represented by proxy and entitled to vote for the election of any
Trustee or Trustees shall be the act of such Shareholders with respect to the election of such Trustee or Trustees, and (ii)&nbsp;with respect to a Contested Election, the affirmative vote of a majority of the Shares outstanding and entitled to vote
for the election of any Trustee or Trustees shall be the act of such Shareholders with respect to the election of such Trustee or Trustee, in each case at any meeting at which a quorum is present with respect to the vote on the election of such
Trustee(s). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Contested Election&#148; shall mean any election of Trustees in
which the number of persons nominated for election as Trustees by Shares entitled to vote for such Trustees in accordance with Section&nbsp;1.9 hereof exceeds the number of Trustees to be elected by Shares entitled to vote for such Trustees, with
the determination that any election of Trustees is a Contested Election to be made by the Secretary or other officer of the Fund prior to the time the Fund mails its initial proxy statement in connection with such election of Trustees. If, prior to
the time the Fund mails its initial proxy statement in connection with such election of Trustees, one or more persons nominated for election as a Trustee by Shares entitled to vote for such Trustee are withdrawn such that the number of persons
nominated for election as Trustee by Shares entitled to vote for such Trustee no longer exceeds the number of Trustees to be elected by Shares entitled to vote for such Trustees, such election shall not be considered a Contested Election. The
determination of whether an election is a Contested Election shall be made on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proposal-by-proposal</FONT></FONT> basis and it is expressly acknowledged that, in the event different
classes or series of Shares are entitled to vote for different Trustees, a Contested Election may occur for some Trustee seats but not others at the same meeting of shareholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholders may vote either in person or by duly executed proxy and each full share
represented at the meeting shall have one vote, all as provided in Article 6 of the Declaration. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cik0001378701-20220824.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 25-August-2022 [05:27:47] {AM}-->
<schema targetNamespace="http://www.gabelli.com/20220824" elementFormDefault="qualified" xmlns:cik0001378701="http://www.gabelli.com/20220824" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:cef="http://xbrl.sec.gov/cef/2022">
<annotation>
<appinfo>
<link:linkbaseRef xlink:type="simple" xlink:href="cik0001378701-20220824_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="cik0001378701-20220824_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="cik0001378701-20220824_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
<import namespace="http://xbrl.sec.gov/cef/2022" schemaLocation="https://xbrl.sec.gov/cef/2022/cef-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>cik0001378701-20220824_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 25-August-2022 [05:27:47] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#SecurityOnly" roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" />
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#RiskOnly" roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllSecuritiesMember" xlink:label="loc_cef_AllSecuritiesMember_205" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_207" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>cik0001378701-20220824_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 25-August-2022 [05:27:47] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link" />
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>cik0001378701-20220824_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 25-August-2022 [05:27:47] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#N2" roleURI="http://xbrl.sec.gov/cef/role/N2" />
<presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllSecuritiesMember" xlink:label="loc_cef_AllSecuritiesMember_205" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_207" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139825859292528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>N-2<br></strong></div></th>
<th class="th"><div>Aug. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001378701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">POS EX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">THE GDL FUND<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Corporate Center<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rye<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10580-1422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">422-3554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoSubstantiveChanges462c', window );">No Substantive Changes, 462(c)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ExhibitsOnly462d', window );">Exhibits Only, 462(d)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Corporate Center<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rye<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10580-1422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">John C. Ball<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ExhibitsOnly462d">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ExhibitsOnly462d</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoSubstantiveChanges462c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoSubstantiveChanges462c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d388267dposex_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cik0001378701-20220824.xsd" xlink:type="simple"/>
    <context id="P08_24_2022To08_24_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001378701</identifier>
        </entity>
        <period>
            <startDate>2022-08-24</startDate>
            <endDate>2022-08-24</endDate>
        </period>
    </context>
    <context id="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001378701</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-24</startDate>
            <endDate>2022-08-24</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="P08_24_2022To08_24_2022">0001378701</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="P08_24_2022To08_24_2022">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="P08_24_2022To08_24_2022">POS EX</dei:DocumentType>
    <dei:EntityWellKnownSeasonedIssuer contextRef="P08_24_2022To08_24_2022" id="hidden55199872">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityRegistrantName contextRef="P08_24_2022To08_24_2022">THE GDL FUND</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="P08_24_2022To08_24_2022">One Corporate Center</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="P08_24_2022To08_24_2022">Rye</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="P08_24_2022To08_24_2022">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="P08_24_2022To08_24_2022">10580-1422</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="P08_24_2022To08_24_2022">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="P08_24_2022To08_24_2022">422-3554</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">John C. Ball</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">One Corporate Center</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Rye</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">10580-1422</dei:EntityAddressPostalZipCode>
    <dei:NoSubstantiveChanges462c contextRef="P08_24_2022To08_24_2022">false</dei:NoSubstantiveChanges462c>
    <dei:ExhibitsOnly462d contextRef="P08_24_2022To08_24_2022">true</dei:ExhibitsOnly462d>
    <dei:EntityEmergingGrowthCompany contextRef="P08_24_2022To08_24_2022">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M<F]P<R]A<' N>&UL4$L! A0#%     @ ,JL8590>G%_N    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ ,JL8
M59E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    "  RJQA5$HS2Q>@#  #Z#P  &
M@($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ ,JL8
M59^@&_"Q @  X@P   T              ( !*PP  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    "  RJQA5EXJ[',     3 @  "P              @ $'#P
M7W)E;',O+G)E;'-02P$"% ,4    "  RJQA5MD)7)C(!   @ @  #P
M        @ 'P#P  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ,JL8520>
MFZ*M    ^ $  !H              ( !3Q$  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ ,JL85660>9(9 0  SP,  !,
M     ( !-!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @
&?A,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>15</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d388267dposex.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="POS EX" original="d388267dposex.htm">d388267dposex.htm</File>
    <File>cik0001378701-20220824.xsd</File>
    <File>cik0001378701-20220824_def.xml</File>
    <File>cik0001378701-20220824_lab.xml</File>
    <File>cik0001378701-20220824_pre.xml</File>
    <File>d388267dex99aiii.htm</File>
    <File>d388267dex99bii.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="19">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d388267dposex.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 2,
   "dts": {
    "definitionLink": {
     "local": [
      "cik0001378701-20220824_def.xml"
     ]
    },
    "inline": {
     "local": [
      "d388267dposex.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cik0001378701-20220824_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cik0001378701-20220824_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cik0001378701-20220824.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/cef/2022/cef-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022_lab.xsd"
     ]
    }
   },
   "elementCount": 189,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 15,
   "memberCustom": 0,
   "memberStandard": 1,
   "nsprefix": "cik0001378701",
   "nsuri": "http://www.gabelli.com/20220824",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d388267dposex.htm",
      "contextRef": "P08_24_2022To08_24_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "true",
     "longName": "995470 - Disclosure - N-2",
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "shortName": "N-2",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d388267dposex.htm",
      "contextRef": "P08_24_2022To08_24_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 1,
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AllRisksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "localname": "AllRisksMember",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "cef_AllSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Securities:"
       }
      }
     },
     "localname": "AllSecuritiesMember",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "localname": "AnnualCoverageReturnRatePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualDividendPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "localname": "AnnualDividendPayment",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualDividendPaymentCurrent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "localname": "AnnualDividendPaymentCurrent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualDividendPaymentInitial": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "localname": "AnnualDividendPaymentInitial",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "localname": "AnnualExpensesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRateCurrentPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualInterestRateInitialPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRateInitialPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualInterestRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRatePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_BdcFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "localname": "BdcFileNumber",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "localname": "BusinessDevelopmentCompanyFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_CapitalStockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "localname": "CapitalStockTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_DistributionServicingFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "localname": "DistributionServicingFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeverageTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_EffectsOfLeverageTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeverageTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ExpenseExampleTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "localname": "ExpenseExampleTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ExpenseExampleYear01": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "localname": "ExpenseExampleYear01",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to10": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "localname": "ExpenseExampleYears1to10",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "localname": "ExpenseExampleYears1to3",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to5": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "localname": "ExpenseExampleYears1to5",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_FeeTableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "localname": "FeeTableAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_FinancialHighlightsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "localname": "FinancialHighlightsAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_HighestPriceOrBid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "localname": "HighestPriceOrBid",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_HighestPriceOrBidNav": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "localname": "HighestPriceOrBidNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationMaximumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationMinimumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "localname": "IncentiveFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "localname": "InterestExpensesOnBorrowingsPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IntervalFundFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "localname": "IntervalFundFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LatestNav": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest NAV"
       }
      }
     },
     "localname": "LatestNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "LatestPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_LatestSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Share Price"
       }
      }
     },
     "localname": "LatestSharePrice",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LoanServicingFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "localname": "LoanServicingFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtPrincipal": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "localname": "LongTermDebtPrincipal",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtStructuringTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LowestPriceOrBid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "localname": "LowestPriceOrBid",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LowestPriceOrBidNav": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "localname": "LowestPriceOrBidNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ManagementFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "localname": "ManagementFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_NetExpenseOverAssetsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "localname": "NetExpenseOverAssetsPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "localname": "NewCefOrBdcRegistrantFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_NoPublicTradingTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "localname": "NoPublicTradingTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_NoTradingHistoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "localname": "NoTradingHistoryTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherAnnualExpense1Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 1.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense1Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpense2Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 2.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense2Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpense3Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 3.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense3Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherAnnualExpensesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_OtherAnnualExpensesPercent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherExpensesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "OtherExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherFeederFundExpensesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "localname": "OtherFeederFundExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherMasterFundExpensesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "localname": "OtherMasterFundExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "localname": "OtherSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "localname": "OtherSecurityDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherSecurityTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "localname": "OtherSecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherTransactionExpense1Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 1.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense1Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpense2Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 2.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense2Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpense3Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 3.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense3Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherTransactionExpensesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_OtherTransactionExpensesPercent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisMaximum",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "localname": "OtherTransactionFeesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "localname": "OutstandingSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityAuthorizedShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityHeldShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityHeldShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityNotHeldShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "localname": "OutstandingSecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PrimaryShelfFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "localname": "PrimaryShelfFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "localname": "PrimaryShelfQualifiedFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_ProspectusLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "localname": "ProspectusLineItems",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "xbrltype": "stringItemType"
    },
    "cef_ProspectusTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "localname": "ProspectusTable",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RegisteredClosedEndFundFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "localname": "RegisteredClosedEndFundFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_ReturnAtMinusFivePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "localname": "ReturnAtMinusFivePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtMinusTenPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "localname": "ReturnAtMinusTenPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtPlusFivePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "localname": "ReturnAtPlusFivePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtPlusTenPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "localname": "ReturnAtPlusTenPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtZeroPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "localname": "ReturnAtZeroPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RiskAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "localname": "RiskAxis",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_RiskFactorsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "localname": "RiskFactorsTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RiskTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "localname": "RiskTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SalesLoadPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "localname": "SalesLoadPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_SecurityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security [Axis]"
       }
      }
     },
     "localname": "SecurityAxis",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_SecurityDividendsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "localname": "SecurityDividendsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "localname": "SecurityLiabilitiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityLiquidationRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "localname": "SecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityVotingRightsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityVotingRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "localname": "SeniorSecuritiesAmount",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesCoveragePerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesCoveragePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Involuntary Liquidating Preference per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SharePriceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "localname": "SharePriceTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_TotalAnnualExpensesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "localname": "TotalAnnualExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_UnderwritersCompensationPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "localname": "UnderwritersCompensationPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledAmount",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "localname": "WarrantsOrRightsExercisePrice",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_AdditionalSecurities462b": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "localname": "AdditionalSecurities462b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "localname": "AdditionalSecurities462bFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "localname": "AdditionalSecuritiesEffective413b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.",
        "label": "Approximate Date of Commencement of Proposed Sale to Public"
       }
      }
     },
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateOrAsapItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r2",
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DelayedOrContinuousOffering": {
     "auth_ref": [
      "r4",
      "r5",
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "localname": "DelayedOrContinuousOffering",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "auth_ref": [
      "r4",
      "r5",
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EffectiveAfter60Days486a": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "localname": "EffectiveAfter60Days486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnDate486a": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnDate486b": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnSetDate486a": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnSetDate486b": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling462e": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "localname": "EffectiveUponFiling462e",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling486b": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "localname": "EffectiveUponFiling486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "localname": "EffectiveWhenDeclaredSection8c",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityInvCompanyType": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).",
        "label": "Entity Inv Company Type"
       }
      }
     },
     "localname": "EntityInvCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "invCompanyType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_ExhibitsOnly462d": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "localname": "ExhibitsOnly462d",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "localname": "ExhibitsOnly462dFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActFileNumber": {
     "auth_ref": [
      "r5",
      "r6",
      "r7",
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "localname": "InvestmentCompanyActFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActRegistration": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "localname": "InvestmentCompanyActRegistration",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "auth_ref": [
      "r5",
      "r6",
      "r7",
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "localname": "NewEffectiveDateForPreviousFiling",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462c": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "localname": "NoSubstantiveChanges462c",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "localname": "NoSubstantiveChanges462cFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_PostEffectiveAmendment": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "localname": "PostEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PostEffectiveAmendmentNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.",
        "label": "Post-Effective Amendment Number"
       }
      }
     },
     "localname": "PostEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_PreEffectiveAmendment": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "localname": "PreEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendmentNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.",
        "label": "Pre-Effective Amendment Number"
       }
      }
     },
     "localname": "PreEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r10": {
   "Name": "Investment Company Act",
   "Number": "270",
   "Publisher": "SEC"
  },
  "r11": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "313"
  },
  "r12": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r13": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "413",
   "Subsection": "b"
  },
  "r14": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "b"
  },
  "r15": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "c"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "d"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "e"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "a"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "b"
  },
  "r2": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r20": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r21": {
   "Name": "Securities Act",
   "Publisher": "SEC",
   "Section": "8",
   "Subsection": "c"
  },
  "r3": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r4": {
   "Name": "Form F-3",
   "Publisher": "SEC"
  },
  "r5": {
   "Name": "Form N-2",
   "Publisher": "SEC"
  },
  "r6": {
   "Name": "Form N-3",
   "Publisher": "SEC"
  },
  "r7": {
   "Name": "Form N-4",
   "Publisher": "SEC"
  },
  "r8": {
   "Name": "Form N-6",
   "Publisher": "SEC"
  },
  "r9": {
   "Name": "Form S-3",
   "Publisher": "SEC"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-22-228896-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-228896-xbrl.zip
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M$HV3-^-OZ/ML^0-CZX$S<9=G"I#Q+-34.U'9YS7W9;TF41",2 ?TCLADK]@
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M.2Y&(!*9,C%HX=STR2X^V%]?V]L@Y P$J-A BGH3='S:OD"W1YT(M84VL4@
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M26L^DOXZS*44N5U'9?\E,B@,B!32.9MU?C,YJ\+3B5L5?1VE^R]02P,$%
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M#V++N7D\B?5*Y(A&>R+R]A7"8?]Y+OX 4$L#!!0    ( ()0/E4E:0!Q&S8
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MULEW0CSP<V(,/ $F,+P."**,_BB1L^"AI+, I)31C_ #[D5)@KY]-> 9<S@
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MK+6I)QP)<A/7A3.CBA7[!_2M%0QQM,ILR.!DV==.:$IQT@E3+8+MU&'X:WC
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M['P0?X5B1*I2@..NZQ0#$]46!=E'S%-G<)\*67JOY^2?Z%8C]QLAN3H^)]V
M\ V*29L]E.4<M%."8406[X:7%ID0"1^HH.O -^\AY?%:3Z6$D!E,8*H[!#<.
M2:7>X\C4,:9 &PVGWPOG<P'CW81)/*/2>'/?^:8L8K@?W7<,$O>JM?L][<?=
MAV42W8-I^TN"PL7:V_T?N:PR=II?9,1 X-MGJMBR+5V8T"T$B'WF)'HS@#'=
M@J)/*'&4QEA[/<I%E5 I,-2A*MB8G -4:+:9-#.RN\^K3;BBC*\6BY/\-%W^
M^-)#W'H9MKZ49,J/C<^TD3IVK,2>#8ZYA7M?1"5JBL+NL59O&\@473O8DIR
M&:JML&01>]#BE<Y^K2'<'S2LJ.PK 73[O2:$KK\K&P*5(\,N7-_\"FO/4VU1
M$HCJ0T38O4ZF[5JDBI-.#0#$5'5BC NG-33[.^J\IGO<F!%4-T2S1I)X0)BS
MC^'.K"P-X58X[8<$)]?!%,O,[1C!]H,:ZH[R[?C'! 166"7?+J#TQ??H)NWW
M8E1M/G/2\IWMAFL\9[L<85*YC>K*M0\=D'?SN6,*8C66]''59"\2E81.)17S
M<]])+(&T'@NYW<$EU,4:K%78R(^4!524<V4 8FAV.$.7UN#.4S9;Z$*24]H"
MC 5#P[HX5JN6HG1@K#?G=%$A(TW"4?U>S5=U?XYG>0<4AM&$DUS^M!=@ME/8
MP*MT"DN5$K2=O1P41$K)(BMO,RJI5EC:;DV/6(4QZ/<82H <FNL&6#U5I:ZH
M:9_XM>@RR3(LXYG<U7NXKG-FA.K6IQ>N)H0R'U\(_Z(VOR;EF$1R5<&H7<)L
M-4_NC%06,XV:VN6YSSHJ1FIBLR(2M4W39KEST)T-# NM<ZS074WK>M:=FS-&
ME)UPW4P&IBB.;-$VO,KQC5@)GAU#Q]S6\Y105Y;TRC-3BZ6WXTG]PVY \01T
MU-4LB.Q;R* Q)(;EC_(9U1BTZAAI*&T->"(^ %/(0EXD>A_5'>(3EM5"Y]O8
MKQM=Q*;>M-9#\K9[;9K+(5A@L_955<J=6VELQ@6&UX#=J=3HM: G='LK6OI>
M<'A?Z>X:JA3-L=P;336S0,78&$OH)VQG[&NJ5\/ARBJYF]'M<6S=(<&(&I75
MTCZW>L9X+?6[W7)A3 252V@$11Q@A+(!H-'F7<&W&82W59XC%X!)Y)1@L+O1
MP6ML6EK!A2(N$5H4\XJLW642Z?("J17)!BT"K[!?*B40L C,G/INF0QN"L4P
M&MT%9:]-Z@\O:1V4J5EC(H$V>**B+"?:A1N)3O/"6JXJ932CQ/G8!N@^B;J6
M2;TX0H0N?,G@LIT'*D5H3?1EF_WJ.& [RW4B3VL9)*E)>IRH*#A5)!K6LJ*R
M[/[2X6\#*T(J62"95Y^X77FL"<7;:_38">*IP84M 0W6XJUH9(=*U<&*V_>K
MAI>7:>FZ TMJ<L#,U2VAZ._I.H0:K*!3GTIMQ0_CC?U>DW+W\&?SQSW>4-46
MQL["?EAE(E3*Q/LHC?(P>?B9#G4 P>R*6R(+N TW/R+K,INJ-J7(]E%PZVS
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M)?O!Y#NB!)6"5F.=?B6L!K>68G.N\^KKZN =5OUN@[/*<D$TJY2@/EI\L_7
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M6*XGFJ72?F94H!%9NV[[&8':?KMTZRZMK=]S@IS1'M#\U8H7D'4,,\6ML1:
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M,#K4IM#K']Z<'?\*L_@P_GAR^+]02P,$%     @ @E ^51GA[EH+!@  <Q@
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M"1C/<R5O_4@>R9P&$J18)HE<B&S&>&6[WG!_I#(=TJ#$B".GP* 4#!-I"I%
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M>U/C2);O__4I,IC;.V;"8,LV8*AJ;K@HJIN9*HH+].S,3DQ,I*6TK4:6W'H
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MK!VJT)RB[WSBS.NB]SG'EMFC24S89D78+TW8+U* 8..H^_1^9/?M,/CA.E,
MIO5@JH:CMDB9=-\C45L;3-1)O=0YE%6=DAY 6F31>@4 %]P<D>&-[$&I<S,<
M=_!J"6Z"L@I-!X2@).?WJ%*QWIV_ZS)QZ:X:\73BH-%QYU3'Z*M4TQ5;J9FR
M&1$W8ZJZRH1>8-$IKW/"=$OJ,).?N--D-7Q&^8J+']4^X^WJ8/'^SO$Z$Y-]
M$;?"\289<*P;P7AACT5.AQ$/F'! L$N[09^D>X11\!;6A.&LK\=EI<:E6UL$
M_@K([P_(9QC"=<L=R7MK:^?F9"V=2RV$\3&_09<97<0 APY?@-8,FD:@5--
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M)=F43,Q@(G?B^4Z+U?3EA2D_'#'W3#W&M'FZN%%MGD8#N$R^>I@[4F=.U<G
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M:>\WAI:SXYJ!_Q^C!=\:NZ-P+ LY\LBRPXRQ)$@V2=XE(%/S49QSUXW@"5^
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M&?T## @.!TF@RPR<W@-C.JZ)ISQVKH4#M ^[A\ !]KMP^K,P1#&0#* 7P:A
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MU$0M'._N)3B9.7N,><C2!;-KQU-/IJ25U)?R^SE&HQY9/20'2;B!G29 P)O
MBM(I4,$!V=8IIDJ#3J%)D6_V&$56P90.F=88R:Z$/!VTB$ R3*D.P,R!2V,)
MF@&=$G)XC%5M$/XR_34>(<TCY#?J/ UZP+@?^8%(S4N) #0UX8D=F-T?$:PZ
MP$8C&\F --H9RD_SV7@\. +,BRV5FDG#R;R36P<?L@3P-I9D05TGO1B[P%49
MVN65004Y!$=-VXUW)\EWQ)YL2<-C7!<4EB(\2H3?#+- P"I]&7J!94.;6R!#
M9*:Q$2BU!2G94F!T Y4Y0HU-:\\.Z*HB*%:#2;,FE5U32R"9;7M6&,W((<'6
M)2:HS^Q>:]&7YO0QOUZ57=?5ZFBN#0(7M'.++#D,RTL)LGCZF$T.@.6WW)8>
M6;0Q@*J,04H34+$E6D%UB:"QT+>YLQ-.)[CD?T2V/TV).5]H,@ 4AO"@7O2B
M(U0*#9$C$V-A%#JA?(!AN_,DR48%\"T9<;,.OF])ON_+.OD@O/Q(\:?<>2 V
M=P="$EI@)W90U!W@5$_"'-^3NB8UFCD;*[N$I!;8'KTA+R'QQ$+=/675E*=G
M[6$(XJ.Y%C7&8:?)>F:H;OP$V*9<2?49LW[LNIC0-7TD)Z0Z(<_FB051ZY^R
M0U) A']KFXGF*=O5EE<D*O)QA)DQHCL"#1]I(7J'!,8S7@O/'W*75)K$NZ&]
M%NP7Y>8X2;WP#=J-^YE1]U-B49]F)OCT!A[E.KMM],I\B>1HSA+K'_H) "BV
MM$K(I3L#F0#,5%I+M9-MHFZ8 %7;$5+E1@=D," K#)6-BD^]TNYB"4XG_UB+
MBJ6RMN@1,6DKOAA/'&\J3?NJP4*/49^87:S\$AT3;TW7WL#W;J%[2XLE>(R&
MJ_0UF(TNRRJK"I""F[--XDCPV(XFY7G#](GJ;2D.M-](:AG:1C#VZ))*L@A(
MUPD:JF$I/4[F2C0$ \^_%<J0@FLISX04!3"CUY#[8]'(=MDI-#A-N2#K5'O$
MYR@?,]J"'6\Y/((^>0(W2$%ROFC/6JQQ9!TM9).7/=%CW RE^XQV/_'6B7ME
MCRG1LG,;+45Q (N"_B?8;#>K=L7-X>*AHJ6V3W[O^8'VO2CC#:VG[2=F8)Y<
M(QMSA"QODZ;R@O>TIR-9]2!>]KP;ZSJ]<2@CQFAX@O^7>A@=0#1L !ZAB)T6
MLQZW>H$O,Z4B%8R*N.]0'VZD68%\)=KP'@]-+KPEQ#C1,6'!30_W#E2;P$:
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M+1QJ*5^Z/!O9L/Y8H!;MQZB6XUZ$A;T@MT8G(P_4Z1M)*]9+T);L2GTQCMW
M5AS[1KD>)8Y3JOJVXGDR94X5SZ>3PJL.)LA$$-10^/'48:O O)JR5<6Q67C:
MV:[B#XKC#YXO5B Q;TLX0W,#=.X_8\A ,AMN 21)8[?(6J'UY">-)2 ^A; >
MP#;# HP]/"DL&U< @LKQ<%T"G!#&$KC>4X03Q$;5]<05Q!-7$7Y!.L)O(R(-
MZAL6,["VD &R:2M*2)&&9&""9M8G>M6>7-R.-'=67IX"/EE'@P"62Y1T1\H=
M/FD)TU?!AIK%%#J]E6=5AD."S- ]>?*[Q&@8.Y)B_,7L?SD'>6*%RDXT-4V[
MF&R#&;HM=&!+!T?PS"S$LB7C4GAD,R H$F[X8NR&J.)%$A/I9P\H?4&$3;+^
MB9$;!:6T%4G:C%U.[K38\JD8HC+)2JU,6\_9';FX[SA*>&Q!&LRE#(L[-[F+
M/<<V<WK\A8)=8N6;_"H;Z2"FX2WP#S_*&[R*,SAXD"^8IO!4KF#L((R-I*DU
M*W $2\\=?'+9C>O=:32/%7 1EA-8:G+[S/C3UN'N[2WE[EWDY_V<:B5%S^MR
M\YXL=O,6K7<^Z"@^G,6^8'6BT\6WTR^C-Q6H2)?(SE@46G!,KAF'V_J%5^K8
M7(DY?>B9X?8+Q65)I?:!WO28ZI[+G?[D+O3G#ELJB/O*BY+R&,-L+.8Z8BOS
M$90I "X3&DFB7CK*,MQG5MU[TO#(!X6E3(JH),VV2F(0^<(HQ'I!&.*R<2XK
MQR6^ (XW/01C#:;C CNXK,C_[(O]6W+CQ QG2"UKF+W&AV>O\7G6$?>4'@7[
M/*WGG 7JG"K4A@\ )/&)\A<./-ZQ&[_TOI_\D(K#"7G)[MGO<,)!95)[6NO*
M<FT#,[MSM;9>9Z?_Q<>3CS\:7^2_*1?FQ'-L$R6M]LSVA2LP2U8[Z92=.VC,
MFMBEK1=5-%MJYBJY0VD\TB.<FB,<+LB<Z8.JS$/X@)$)B2(/2NC81M;E:I::
M'^0+;-J9&W@#3H;)/,IPQ5*)R4K;3$)N4J6]>M+49!RVVYIT)RCJ0G4 C5<Y
MO[@%G@&U6GYJ75,VG>S9-R&$>LZXDVLBL<.0RT.=210 4\[-W+S*[CPK/+J@
MN41IZ),(I* I]Y7B# "I(*."Q$"76SPZ]@1UJ0 -R  ;N2J7%64)'53H@'I+
MN0TX>BY3=(O#6]5 ,BFPV%DMEUN=LJ7EE@S3*?1I.'9-D.IJ*YO%C(](^5-S
M6UJPHVH1*,H\"/"P$GLRBET7B7ZR3>L,2^F'*5?)LD,I.?8'R6Y(&Z<<*T;Q
MS$ )-<UZ?/"=01 R%2VW21.3ULT8@-+<1R//C ^- 1;%[< Q&BA'&S!)=QO(
MD+2)CPPHFPN#?9#7CB:4=C#G,0$]RG/ZHU"J%>TAAI.X262'U$-C!T;:1D;I
M.=6-1T]:J,5XM85:/D<!^EDELY7*UDE,HD$2YI@$&"AU[.6O/IH=&"@H,@(7
M"".1G>I6L,+ 55!Q8YD7U^# ?O[I^3=U*CXBA7/<%5=K,'-IZ(Q" K0.O!7T
M%D<;BE4\UC@.RX1'TBC*6(OIRA4]MHS<CN6Y_K5H)4)O*+G1G?0U))>K);X?
M=215$"#OWT $\BAXZYEQ\)Z,==##YIEP>U6:0KA#(#]B78HE%>"&E$ O*)V.
M%?EZJ29H" SO/+J[-Z"3:5)9);:[Q3>XCLJNL%.LE&YB[7WY>_F*/>#NU;QF
M--MH2C?K-%EMB3;IHM@E3M+JMOENT]AI'QPT][<U!ZH8_5,R^M:K9?3?O$0O
MZ,GPO$"5N9*AAYO!U'EZ:+FHR/2!UA?QL512.1J6=&259"]S:!V>^^&*.$L!
M/E'=USJ[G(+NK_D_,YI[W>:.T6FUZL5=Q$,[@=.K9]E8KP-G\9F[-VE)PKX#
MGI6/HP6<X!<?E-$[M+9<A? QK*=DSOD_H=]6=W]1E[F\ ;E><H%@(CVT09H<
M+^CSS!MVK1Y6Q?KQG*ZB1$^4=(1.]EM-@QE[P ![<,Z)8"4^^YYWXTQ=.2JC
M91S*$*S<R-!J$+O'%C(OD!X[V;!2S;H^0R]RI=*;=D7)+&2=_^UJ&WXQ=VDA
M#_:;[+N'AM1+C\-)X6_X""S.!<PKL'F=70C7#:;.+4A]3AQXOU*#GY0[ME\M
M=_Q.<<TIN(E-8(CG7I@*7JS ^Z3@[;Q:\/Z6>+*70&W2]_X[!$WGI_("NNH"
MV"50A>?]C0+)['40!:RC@L43PZ)5P:*"Q2PLVAL/B]3)2H=%"94H5(".C8@3
M>@/H,MIK@1??>'B%'EG7ZMK Q]$A9'M6DJU"U\U3Z'_ '8JN$\H7A$$W:->=
M>$&X(^ QDY)=8E>[-+XMN):^8G'E(.PN!&%G"1#6C.U7@$+;38)?,)X<@[^B
M;)YT)DS2:&*<9'N[P#G=,Z'_"EO/@JW6:\"6+P:.JL&NTQ44O&3B.+J25*@:
MFC<IS8UB"F*>9BG_4]KE+3,C-#=C-15',_94A3,,T$#.R I9HZS<L"V9;#V5
MCNI,DZ(,C ^'F-:$A2I\@3YHLB=2F!"V%6(LG'14J!?2KI8DLR_.9RD:^<)*
MI3*.S<1H1IE1*=1G:!833,8R>B\A0!(90+,U';".-Y<RRW,<[F/5DJCLA20P
M'3,&=32*E$,8?IE$'\@$6AR9)6YM%9?CJZ!-Q[MC%$H^'#'AQBEA& LPID"E
M,;^WQQ0L"?U26 .MH8K047!)7%2XI-A("C@YEU2)Z^DR B[1:74P^<(>U MV
ME=+.: >#U'+*N@=H*$]VW?48)B#*")56\Z?<QNLIQ6TGDY,MS:!!Q5.?<,>D
M.W6D R(CJ[_&.<9,<CSU:H+H,DA5[/=9V&_[-;#?M&A'^L,H]PRCR@=\$Y-V
MN(Z<EM4L\$&5LG)K>U& J31V8#I>*BRG6-'4::MQWXIRDE2;9"AS&UH"UDL8
MGC-79'5_REJBFZL:HB]*TH+C]&T0:* ! A<'6:T*(L1J$^8FJ9 ORZ/510O$
M-)?VEI<KL4XF8VS5]LK<[_+# ,4>>)2E&H_,#K+Q +IB2HJ[8H9IY+MV,)(=
MYKBMBFBX+ Z*S&J,;6PL^]4>5M!3XB'V^6-@@ PD] 7+7!J3B6RP736<8AY8
M5Y5^,A/DY;*D3&[(@,Q >O7FJB!SO!#ODL>NYPS?W_PS/"(D+K"%A=]T$629
M5J,S-9.XJ[)8Y;JLM5)*PW&^#=:TBAD 9RX,KD0M]H7#=1FZ7$2IUOI"F2)?
M3V+AM>:B R53+W%%FYAH7S(>R:]LBH'J>RZF EFI1I7J71T1GX=^S,VG'SPA
MCK'VB2H5E@(R</RQX*Z^8*R,,%+5O.:$3*N3#'2&B1.1&WAPVE&!&ND:"$ED
M(2&V0NKS(-7:?*0"YZLO8O6+V7Q\?XPN>5J98BM3K(*8/1/0)PL8Z%+*4C5M
M-S]7F%F F=;^6KA2K;?QF*$:H3,'FOE'L]01!X^CQ9K<XC./K%5+#Y"-5F;<
MT'DJ&<\=E5N@=G6+,E0R.;B6]T#73%98?QZL?WYU6,\90^:>Y<D"@__NJ;O/
MX.,!5?R*85D&<S*.)#5Z8RZ<.5^1Q4R=<J@BPNPXC#TJ+[)=LW$H]VH<]SJG
MOT"U2$K7E]J!"GUSQ8ZY!82^/%FF"%]PW[&3&N+$!^C86&!KP<P?V\>[6M!L
M*%T]L4)/V59J!=(>'_F&KBQ.IU+NY'T8.N-1;X E M.W^\D\DE'LLEZV+&:\
MG?5<<K':AWBJE#'HQ[X/E;RI343Z;$QCYZI,D4R5KZMT4%J;.:?XE5Q><\[V
M\_<NKF@@395I:H(6=3719S,%[+(R*ZKKI48=WQ%5-BV9CZOGLKSA3E;OU(U;
MGADIFD^9'LGO1C-[L$7RX>.3J;TJ.RTY-J@:KG(#9%VM+(5,?-OS8SM[%EN(
M2,2OL&3U4L_"VK]4B2W!";G_>!"OSFJ3N^,KK[XN!)=L0NKRKWG3^8C-5%I"
M%72PTBGJY$A97)?U!I0>Z9=1(DITA<R]\L6O$F>>$A].*Q]Q[21Z-9F$T-,H
M45MZ]:?0 TABR4S^^3*^XO?/PN_C37CUK%[K0O&,2CW!50#N1IETQ:LPZ2YO
MT9U-MUW:QIM$B$EU.!-8D3G*+&'96S',H=5Z2,(Q32V I1+6S(PI#)[I8D58
M6\H>8R'7S'DA[6JDN9>TF*T68 <EW"-_:TG<(AZQZ,PMPI%G2;&#K$,X3OY<
MI*-;DLO&[!FW$88=:-^H1W<*)65AD^W,>*82]U.Z+.MX'+FJYHPLH52V +IV
M#:<Q)R4TDM[2%6ZP>#A0K[[)"T=*X\3IYL]H^89FKCBI-.+WX5>0<=W"H9L2
M_$R,=U:<SR?5O,DAB>!<U@Y7RC$K-VMU?%-@'>"E")JKY\U31>@#9(/V*?5S
M>;5A7\ !9[  S7A36""Y?/K*".4Y*7ZI@FD56QOKCB)=2S.I&U6&7[JJB(8=
MJ$O(9AADMU6N4I;"7\4X2K]#08 O[WM1N( 0Z+*9I+_T];?+4U3EK'M& NEL
M/($D%)%1AA.'B3*"S3AOTK?EED VK]E6.0_/DK'=V?@3/2;R]ZI$_N>%Q=[&
MPV*.14/=A9DS;$A?<-H#O'I MRX^K0*[L5*WM(UDK4AQA3#NNG@CILS#F)=*
M00[^>=D4J7%D$BOD@#HQ"WZX=?LM!:-77.)9N,3^QG.))<O.VZEKCIZK\'RI
MP73YPO-IGK=IA><WJ=I\^F2T[FKS:9_T:ZLVGS-9OY=J\^LI,5])ER>6+@<;
M+UU*O&CHJG()32K2T0'*QB*^3A+A(7U-EE#:*[PCZ/8])OZ012OP=M8)WBCK
MV##/:9W(&@%\Y\5US)F%-\'0O6BFL"<J6B6^P G9!6F?1$GU?"T8U#<33_Z
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M8O<59907)&CI,P%\T?>L*?PZ"L?.\?\'4$L! A0 %     @ @E ^500'30'
M @  = H  !H              ( !     &-I:S P,#$S-S@W,#$M,C R,C X
M,C0N>'-D4$L! A0 %     @ @E ^50,A3BOL 0  PP4  !X
M ( !^ (  &-I:S P,#$S-S@W,#$M,C R,C X,C1?9&5F+GAM;%!+ 0(4 !0
M   ( ()0/E46JRHFI0$  ,(&   >              "  2 %  !C:6LP,# Q
M,S<X-S Q+3(P,C(P.#(T7VQA8BYX;6Q02P$"%  4    " ""4#Y5%^&FE:4!
M  #; P  '@              @ $!!P  8VEK,# P,3,W.#<P,2TR,#(R,#@R
M-%]P<F4N>&UL4$L! A0 %     @ @E ^525I '$;-@  ?AD! !0
M     ( !X@@  &0S.#@R-C=D97@Y.6%I:6DN:'1M4$L! A0 %     @ @E ^
M51GA[EH+!@  <Q@  !,              ( !+S\  &0S.#@R-C=D97@Y.6)I
M:2YH=&U02P$"%  4    " ""4#Y5,-/&\BH[  #H% ( $0
M@ %K10  9#,X.#(V-V1P;W-E>"YH=&U02P4&      < !P#N 0  Q(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
